INTEL CORP
SC 13D, 1997-03-10
SEMICONDUCTORS & RELATED DEVICES
Previous: PHOENIX STRATEGIC ALLOCATION FUND INC, 497, 1997-03-10
Next: MALLINCKRODT GROUP INC, 8-K, 1997-03-10



               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C. 20549
                                
                          SCHEDULE 13D
                                
            Under the Securities Exchange Act of 1934
                                
                          XIRCOM, INC.
                        (Name of Issuer)
                                
                          Common Stock
                 (Title of Class of Securities)
                                
                            983922105
                         (CUSIP Number)
                                
                      F. Thomas Dunlap, Jr.
          Vice President, General Counsel and Secretary
                        Intel Corporation
                 2200 Mission College Boulevard
                      Santa Clara, CA 95052
                    Telephone: (408) 765-8080
          {Name, Address and Telephone Number of Person
        Authorized to Receive Notices and Communications)
                                
                        February 28, 1997
                  (Date of Event which Requires
                    Filing of this Statement)
                                
If the filing person has previously filed a statement on Schedule
13G  to  report  the  acquisition which is the  subject  of  this
Schedule  13D, and is filing this schedule because of Rule  13d-1
(b)(3) or (4), check the following box [ ].

The  information  required on the remainder of  this  cover  page
shall  not be deemed to be "filed" for the purpose of Section  18
of  the  Securities  Exchange Act of 1934  ("Act")  or  otherwise
subject  to the liabilities of that section of the Act but  shall
be subject to all other provisions of the Act.

<PAGE>

CUSIP No. 983922105      SC 13D         Page 2 of 11 Pages

1.   NAME OF REPORTING PERSON                      Intel
                                                   Corporation
     S.S.  OR  I.R.S. IDENTIFICATION NO. OF  ABOVE 94-1672743
     PERSON
                                                   
2.   CHECK  THE APPROPRIATE BOX IF A MEMBER  OF  A      (a) [   ]
     GROUP                                              (b) [   ]
                                                   
3.   SEC USE ONLY                                  
                                                   
4.   SOURCE OF FUNDS                               Working
                                                   Capital
                                                   
5.   CHECK  BOX IF DISCLOSURE OF LEGAL PROCEEDINGS          [   ]
     IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
                                                   
6.   CITIZENSHIP OR PLACE OF ORGANIZATION          Delaware
                                                    
  NUMBER OF   7.     SOLE VOTING POWER              4,026,308
   SHARES                                           
BENEFICIALLY  8.     SHARED VOTING POWER            N/A
  OWNED BY                                          
    EACH      9.     SOLE DISPOSITIVE POWER         4,026,308
  REPORTING                                         
 PERSON WITH  10.    SHARED DISPOSITIVE POWER       N/A
                                                   
11.  AGGREGATE AMOUNT BENEFICIALLY OWNED  BY  EACH 4,026,308
     REPORTING PERSON
                                                   
12.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)          [   ]
     EXCLUDES CERTAIN SHARES
                                                   
13.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW          16.7%
     (11)
                                                   
14.  TYPE OF REPORTING PERSON                                  CO

<PAGE>

CUSIP No. 983922105      SC 13D         Page 3 of 11 Pages

Item 1.   Security and Issuer.
                 
          (a)    Name and Address of Principal Executive Offices
                 of Issuer:
                 Xircom, Inc.
                 2300 Corporate Center Drive
                 Thousand Oaks, California 91320
                 
          (b)    Title and Class of Equity Securities:   Common
                 Stock
                 
Item 2.   Identity and Background
                 
          (a)    Name of Person Filing:    Intel Corporation
                 
                                           The executive
                                           officers and
                                           directors of Intel
                                           Corporation are set
                                           forth on Appendix A
                                           hereto.
                                           
          (b)    State of Incorporation:   Delaware
                                           
          (c)    Principal Business:       Manufacturer of
                                           microcomputer
                                           components, modules
                                           and systems
                 
          (c)    Address of Principal Business and Principal
                 Office:
                 
                 2200 Mission College Boulevard
                 Santa Clara, CA 95052-8119
                 
          (d)    Criminal Proceedings:
                 
                 During the last five years neither the
                 Reporting Person nor any officer or director of
                 the Reporting Person has been convicted in any
                 criminal proceeding.
                 
          (e)    Civil Proceedings:
                 
                 During the last five years neither the
                 Reporting Person nor any officer or director of
                 the Reporting Person has been party to any
                 civil proceeding of a judicial or
                 administrative body of competent jurisdiction
                 as a result of which such person would have
                 been subject to any judgment, decree or final
                 order enjoining future violations of or
                 prohibiting or mandating activities subject to
                 Federal or State securities laws or finding any
                 violation with respect to such laws.
                 
Item 3.   Source and Amount of Funds or Other
                 
          Funds for the purchase of the securities are derived
          from the Reporting Person's working capital.
          $52,278,313.88 was paid to acquire 2,516,405 shares of
          Common Stock of the Issuer.  Additional amounts, which
          vary depending on the date of exercise, will be paid
          should the Reporting Person exercise the Warrant (as
          defined in Item 4).
                 
<PAGE>

CUSIP No. 983922105      SC 13D         Page 4 of 11 Pages

Item 4.   Purpose of the Transaction
                 
          The Reporting Person acquired the Common Stock and the
          Warrant  (as  described in Item  5(c),  below)  as  an
          investment   and  in  connection  with  a   technology
          agreement between the Issuer and the Reporting  Person
          pursuant to which the Issuer and Reporting Person will
          work  together to further advance mobile  connectivity
          solutions for high performance business computing.  In
          addition  to the 2,516,405 shares of Common  Stock  of
          the  Issuer  acquired  by the  Reporting  Person,  the
          Reporting   Person  also  acquired  a   warrant   (the
          "Warrant")  to  purchase  up to  1,509,903  shares  of
          Common  Stock  of  the Issuer.  The shares  of  Common
          Stock   subject   to  the  Warrant  are   vested   and
          immediately exercisable .  The exercise price for  the
          shares increases periodically throughout the time that
          the  Warrant is in effect, pursuant to a schedule  set
          forth in the Warrant.  The Warrant expires on February
          27, 2002.
                 
Item 5.   Interests in Securities of the Issuer.
                 
          (a)    Number of Shares        4,026,308 shares*
                 Beneficially Owned:
                                         
                 Number of Shares        4,026,308 shares*
                 Beneficially Owned:
                                         
                 Percent of Class:       16.7%*   (based    upon
                                         24,158,349  shares*  of
                                         common            stock
                                         outstanding, determined
                                         from    representations
                                         made  by the Issuer  to
                                         the Reporting Person in
                                         connection   with   the
                                         closing    under    the
                                         Purchase Agreement  (as
                                         defined below)
                                         
          (b)    Sole Power to Vote,     
                 Direct the Vote of, or  
                 Dispose of Shares:      4,026,308 shares*
                                         
                 Shared Power to Vote,   
                 Direct the Vote of, or  
                 Dispose of Shares:      None
                 
          (c)    Recent Transactions:
                 
                 On  February 28, 1997, pursuant to the terms of
                 that  certain Common Stock and Warrant Purchase
                 Agreement  dated as of January  13,  1997  (the
                 "Purchase  Agreement"),  the  Reporting  Person
                 purchased (I) 2,516,405 newly issued shares  of
                 Common Stock of the Issuer at a price per share
                 of $20.775, and (ii) the Warrant to
                 
- -----------------------
*  Includes  the additional shares (up to 1,509,903)  of  Common
Stock  that the Reporting Person has a right to acquire pursuant
to  the  Warrant  (as defined and described in  Item  4).   Such
shares are beneficially owned by the Reporting Person under Rule
13d-3  because the Reporting Person has a right to acquire  such
shares within the next 60 days.
                 
<PAGE>           
                 
CUSIP No. 983922105      SC 13D         Page 5 of 11 Pages
                 
                 purchase  up  to  1,509,903  shares  of  Common
                 Stock.   See  the  Purchase Agreement  and  the
                 Warrant,  each of which has been  filed  as  an
                 Exhibit hereto, for additional details.
                 

          (d)    Rights with Respect to Dividends or     
                 Sales Proceeds:                         N/A
                                                         
          (e)    Date of Cessation of Five Percent       
                 Beneficial Ownership:                   N/A

                 
Item 6.   Contracts,     Arrangements,     Understandings     or
          Relationships  With  Respect  to  Securities  of   the
          Issuer.
                 
          Pursuant to the Investor Rights Agreement between  the
          Reporting Person and the Issuer, the Reporting  Person
          has,   under  certain  circumstances,  various  rights
          related  to (a) registration of the Common Stock  that
          the Reporting Person owns, (b) participation in future
          sales  and issuances of securities by the Issuer,  (c)
          maintaining  its ownership percentage in  the  Issuer,
          (d) receiving various public filings directly from the
          Issuer on a periodic basis, and (e) the opportunity to
          acquire the Issuer or certain assets of the Issuer  if
          the  Issuer  seeks  other offers or  receives  certain
          unsolicited offers.  The Reporting Person has  certain
          standstill obligations relating to its acquisition  of
          shares  of  Common  Stock of the  Issuer  and  certain
          restrictions  on  its  voting  rights.   The  Purchase
          Agreement   also  contains  certain  restrictions   on
          transfer of the Common Stock by the Reporting  Person.
          See  the  Investor Rights Agreement,  attached  as  an
          Exhibit  hereto,  for a further description  of  these
          provisions.
                 
Item 7.   Material to Be Filed as Exhibits.
          Exhibit 1    Xircom,  Inc.  Common Stock  and  Warrant
                       Purchase Agreement, of January  13, 1997,
                       between    Xircom,   Inc.    and    Intel
                       Corporation.
                       
          Exhibit 2    Warrant  to  Purchase  Shares  of  Common
                       Stock of Xircom, Inc., dated February 28,
                       1997.
                       
          Exhibit 3    Investor Rights Agreement, dated February
                       28,  1997, between Xircom, Inc. and Intel
                       Corporation.
                       
          Exhibit 4    Press  Release  of  Xircom,  Inc.,  dated
                       January 16, 1997.
                       
          Exhibit 5    Press  Release  of  Xircom,  Inc.,  dated
                       March 3, 1997.

<PAGE>

CUSIP No. 983922105      SC 13D         Page 6 of 11 Pages


                            SIGNATURE
                                
After  reasonable  inquiry and to the best of  my  knowledge  and
belief,  I  certify  that  the  information  set  forth  in  this
statement is true, complete and correct.

Dated as of March 7, 1997.       
                                 
                                 INTEL CORPORATION
                                 
                                 /s/F. Thomas Dunlap, Jr.
                            By:  F. Thomas Dunlap, Jr.
                                 Vice President, General counsel
                                 and Secretary

<PAGE>

CUSIP No. 983922105      SC 13D         Page 7 of 11 Pages


                           APPENDIX A
                                
                            DIRECTORS
                                
The following is a list of all Directors of Intel Corporation and
certain  other  information with respect to each  Director.   All
Directors are United States citizens.

Name:             Craig R. Barrett
                  
Business          2200 Mission College Boulevard, Santa Clara,
Address:          CA 95052
                  
Principal         Executive Vice President and Chief Operating
Occupation:       Officer of Intel Corporation
                  
Name, principal   Intel Corporation, a manufacturer of
business and      microcomputer components, modules and systems.
address of        2200 Mission College Boulevard
corporation or    Santa Clara, CA 95052
other
organization on
which employment
is conducted:
                  
                  
Name:             Winston H. Chen
                  
Business          Paramitas Foundation, 3945 Freedom Circle,
Address:          Suite 760, Santa Clara, CA 95054
                  
Principal         Chairman of Paramitas Foundation
Occupation:
                  
Name, principal   Paramitas Foundation, a charitable foundation.
business and      3945 Freedom Circle, Suite 760
address of        Santa Clara, CA 95054
corporation or
other
organization on
which employment
is conducted:
                  
                  
Name:             Andrew S. Grove
                  
Business          2200 Mission College Boulevard, Santa Clara,
Address:          CA 95052
                  
Principal         President and Chief Executive Officer of Intel
Occupation:       Corporation
                  
Name, principal   Intel Corporation, a manufacturer of
business and      microcomputer components, modules and systems.
address of        2200 Mission College Boulevard
corporation or    Santa Clara, CA 95052
other
organization on
which employment
is conducted:
                  
<PAGE>

CUSIP No. 983922105      SC 13D         Page 8 of 11 Pages
                  
Name:             D. James Guzy
                  
Business          295 North Bernardo, Mountain View, CA 94043
Address:
                  
Principal         Chairman of The Arbor Company
Occupation:
                  
Name, principal   The Arbor Company, a limited partnership
business and      engaged in the electronics and computer
address of        industry.
corporation or    295 North Bernardo
other             Mountain View, CA 94043
organization on
which employment
is conducted:
                  
                  
Name:             Gordon E. Moore
                  
Business          2200 Mission College Boulevard, Santa Clara,
Address:          CA 95052
                  
Principal         Chairman of the Board of Intel Corporation
Occupation:
                  
Name, principal   Intel Corporation, a manufacturer of
business and      microcomputer components, modules and systems.
address of        2200 Mission College Boulevard
corporation or    Santa Clara, CA 95052
other
organization on
which employment
is conducted:
                  
                  
Name:             Max Palevsky
                  
Business          924 Westwood Boulevard, Suite 700, Los Angeles
Address:          CA 90024
                  
Principal         Industrialist
Occupation:
                  
Name, principal   Self-employed.
business and
address of
corporation or
other
organization on
which employment
is conducted:
                  
                  
Name:             Arthur Rock
                  
Business          One Maritime Plaza, Suite 1220, San Francisco,
Address:          CA 94111
                  
Principal         Venture Capitalist
Occupation:
                  
Name, principal   Arthur Rock and Company, a venture capital
business and      firm.
address of        One Maritime Plaza, Suite 1220
corporation or    San Francisco, CA 94111
other
organization on
which employment
is conducted:
                  
<PAGE>

CUSIP No. 983922105      SC 13D         Page 9 of 11 Pages
                  
Name:             Jane E. Shaw
                  
Business          c/o Intel Corporation, 2200 Mission College
Address:          Boulevard, Santa Clara, CA 95052
                  
Principal         Founder of The Stable Network, a
Occupation:       biopharmaceutical consulting company
                  
Name, principal   c/o Intel Corporation
business and      2200 Mission College Boulevard
address of        Santa Clara, CA 95052
corporation or
other
organization on
which employment
is conducted:
                  
                  
Name:             Leslie L. Vadasz
                  
Business          2200 Mission College Boulevard, Santa Clara,
Address:          CA 95052
                  
Principal         Senior Vice President, Director, Corporate
Occupation:       Business Development, Intel Corporation
                  
Name, principal   Intel Corporation, a manufacturer of
business and      microcomputer components, modules and systems.
address of        2200 Mission College Boulevard
corporation or    Santa Clara, CA 95052
other
organization on
which employment
is conducted:
                  
                  
Name:             David B. Yoffie
                  
Business          Harvard Business School, Soldiers Field Park 1-
Address:          411, Boston, MA 92163
                  
Principal         Max and Doris Starr Professor of International
Occupation:       Business Administration
                  
Name, principal   Harvard Business School, an educational
business and      institution.
address of        Harvard Business School
corporation or    Soldiers Field Park 1-411
other             Boston, MA 92163
organization on
which employment
is conducted:
                  
                  
Name:             Charles E. Young
                  
Business          405 Hilgard Avenue, Los Angeles, CA 90024
Address:
                  
Principal         Chancellor
Occupation:
                  
Name, principal   University of California at Los Angeles, an
business and      educational institution.
address of        405 Hilgard Avenue
corporation or    Los Angeles, CA 90024
other
organization on
which employment
is conducted:


                  
<PAGE>

CUSIP No. 983922105      SC 13D         Page 10 of 11 Pages

                       EXECUTIVE OFFICERS
                                
The  following  is  a  list of all executive  officers  of  Intel
Corporation excluding executive officers who are also  directors.
Unless  otherwise indicated, each officer's business  address  is
2200 Mission College Boulevard, Santa Clara, CA 95052-8119, which
address  is Intel Corporation's business address.  All  executive
officers are United States citizens.

Name:       Frank C. Gill
Title:      Executive Vice President; General Manager, Internet
            and Communications Group
Address:    5200 N.E. Elam Young Parkway, Hillsboro, OR 97124-
            6497
            
Name:       Paul S. Otellini
Title:      Executive Vice President; Director, Sales and
            Marketing Group
            
Name:       Gerhard H. Parker
Title:      Executive Vice President, General Manager, Technology
            and Manufacturing Group
            
Name:       Ronald J. Whittier
Title:      Senior Vice President; General Manager, Content Group
            
Name:       Albert Y. C. Yu
Title:      Senior Vice President; General Manager,
            Microprocessor Products Group
            
Name:       Michael A. Aymar
Title:      Vice President; General Manager, Desktop Products
            Group
            
Name:       Andy D. Bryant
Title:      Vice President and Chief Financial Officer
            
Name:       G. Carl Everett, Jr.
Title:      Senior Vice President, General Manager, Desktop
            Products Group
            
Name:       F. Thomas Dunlap, Jr.
Title:      Vice President, General Counsel and Secretary
            
Name:       Patrick P. Gelsinger
Title:      Vice President, General Manager, Desktop Products
            Group
Address:    5200 N.E. Elam Young Parkway, Hillsboro, OR 97124-
            6497
            
Name:       John H. F. Miner
Title:      Vice President, General Manager, Enterprise Server
            Group
Address:    5200 N.E. Elam Young Parkway, Hillsboro, OR 97124-
            6497
            
Name:       Stephen P. Nachtsheim
Title:      Vice President; General Manager, Mobile/Handheld
            Products Group
            
Name:       Ronald J. Smith
Title:      Vice President, General Manager, Computing
            Enhancement Group
            
<PAGE>

CUSIP No. 983922105      SC 13D         Page 11 of 11 Pages

                          EXHIBIT INDEX
                                
                                                    Sequentially
                                                      Numbered
Exhibit No.  Document                                   Page
                                                          
Exhibit 1    Xircom,   Inc.   Common   Stock   and      1.1
             Warrant   Purchase   Agreement,    of
             January   13,  1997, between  Xircom,
             Inc. and Intel Corporation.
                                                          
Exhibit 2    Warrant to Purchase Shares of  Common      2.1
             Stock    of   Xircom,   Inc.,   dated
             February 28, 1997.
                                                          
Exhibit 3    Investor   Rights  Agreement,   dated      3.1
             February  28,  1997, between  Xircom,
             Inc. and Intel Corporation.
                                                          
Exhibit 4    Press  Release of Xircom, Inc., dated      4.1
             January 16, 1997.
                                                          
Exhibit 5    Press  Release of Xircom, Inc., dated      5.1
             March 3, 1997.




                            EXHIBIT 1
                                
                    COMMON STOCK AND WARRANT
                                
                       PURCHASE AGREEMENT
                                
<PAGE>

                          XIRCOM, INC.
                                
                    COMMON STOCK AND WARRANT
                                
                       PURCHASE AGREEMENT
                                
This   Common   Stock  and  Warrant  Purchase   Agreement   (this
"Agreement") is made and entered into as of January 13, 1997,  by
and   between   Xircom,  Inc.,  a  California  corporation   (the
"Company"),  and  Intel Corporation, a Delaware corporation  (the
"Investor").

                          R E C I T A L
                                
WHEREAS,  the  Company desires to sell to the Investor,  and  the
Investor  desires  to purchase from the Company,  shares  of  the
Company's  Common  Stock  and a Warrant  to  purchase  additional
shares  of the Company's Common Stock on the terms and conditions
set forth in this Agreement;

NOW,  THEREFORE, in consideration of the foregoing  recital,  the
mutual  promises  hereinafter  set  forth,  and  other  good  and
valuable consideration, the receipt and sufficiency of which  are
hereby acknowledged, the parties hereto agree as follows:

1.   AGREEMENT TO PURCHASE AND SELL STOCK.

     1.1   Authorization.  As of the Closing (as defined  below),
the  Company's  Board  of  Directors  will  have  authorized  the
issuance, pursuant to the terms and conditions of this Agreement,
of up to the number of shares of the Company's Common Stock equal
to twelve and one-half percent (12.5%) of the number of shares of
the   Company's   Common  Stock  and  other   voting   securities
outstanding on the day immediately preceding the date of  Closing
minus  100 shares ("Purchased Shares") PLUS the number of  shares
of the Company's Common Stock equal to seven and one-half percent
(7.5%) of the number of shares of the Company's Common Stock  and
other  voting  securities  outstanding  on  the  day  immediately
preceding  the date of Closing ("Warrant Shares") shares  of  the
Company's Common Stock, $0.001 par value (the "Common Stock").

     1.2   Agreement  to  Purchase and Sell  Common  Stock.   The
Company hereby agrees to sell to the Investor at the Closing, and
the  Investor agrees to purchase from the Company at the Closing,
the  Purchased Shares at a price per share equal to the Per Share
Purchase Price.

     1.3   Per  Share  Purchase Price.  The "Per  Share  Purchase
Price" shall be $20.775.

     1.4   Agreement to Purchase and Sell Warrant.   The  Company
hereby  agrees to issue to the Investor at the Closing a  Warrant
(the  "Warrant")  to  purchase the Warrant  Shares  in  the  form
attached hereto as Exhibit A.

     1.5   Compliance with HSR Requirements.  Promptly after  the
execution  hereof,  the  Company  and  the  Investor  shall  each
complete and file their respective premerger notification

<PAGE> 2

report  forms  under  the HSR Act (as defined  in  Section  3.6).
After the filing thereof, the Company and the Investor shall  use
all  reasonable  efforts  to comply with  the  HSR  Requirements;
provided,  however,  that neither the Company  nor  the  Investor
shall  be  under  any obligation to comply with  any  request  or
requirement imposed by the Federal Trade Commission (the  "FTC"),
the  Department of Justice (the "DofJ") or any other governmental
authority  in  connection  with  the  compliance  with  the   HSR
Requirements if the Company or the Investor, in the  exercise  of
such  entity's  sole discretion, elects not to  do  so.   Without
limiting the generality of the foregoing, neither the Company nor
the Investor shall be obligated to comply with any request by, or
any  requirement of, the FTC, the DofJ or any other  governmental
authority:  (i)  to  disclose  information  the  Company  or  the
Investor, as the case may be, desires to keep confidential;  (ii)
to  dispose of any assets or operations; or (iii) to comply  with
any  restriction  on  the  manner in  which  they  conduct  their
respective operations.

2.   CLOSING

     2.1   The  Closing.  The purchase and sale of the  Purchased
Shares  and the Warrant will take place at the offices of Gibson,
Dunn & Crutcher, 2029 Century Park East, Los Angeles, California,
at  10:00  a.m.  California time, within three (3) business  days
after  the  conditions set forth in Articles 5 and  6  have  been
satisfied, or at such other time and place as the Company and the
Investor  mutually agree upon (which time and place are  referred
to  in  this  Agreement as the "Closing").  At the  Closing,  the
Company  will  deliver  to  the  Investor  the  Warrant   and   a
certificate  representing  the  Purchased  Shares,  all   against
delivery  to  the  Company by the Investor of the  full  purchase
price of the Purchased Shares, paid by wire transfer of funds  to
the Company.

3.    REPRESENTATIONS AND WARRANTIES OF THE COMPANY.  The Company
hereby   represents  and  warrants  to  the  Investor  that   the
statements in this Section 3 are true and correct, except as  set
forth in the Disclosure Letter from the Company dated January 13,
1997 (the "Disclosure Letter").

     3.1   Organization,  Good Standing and  Qualification.   The
Company is a corporation duly organized, validly existing and  in
good  standing under the laws of the State of California and  has
all  corporate power and authority required to (a) carry  on  its
business  as  presently  conducted,  and  (b)  enter  into   this
Agreement,  the Investor Rights Agreement (as defined in  Section
5.8)   and  the  Warrant,  and  to  consummate  the  transactions
contemplated hereby and thereby.  The Company is qualified to  do
business  and is in good standing in each jurisdiction  in  which
the  failure to so qualify would have a Material Adverse  Effect.
As  used  in  this Agreement, "Material Adverse Effect"  means  a
material adverse effect on, or a material adverse change in, or a
group of such effects on or changes in, the business, operations,
financial condition, results of operations, prospects, assets  or
liabilities of the Company.

     3.2   Capitalization.  As of the date of this Agreement  the
capitalization of the Company is as follows:

<PAGE> 3

          (a)   Preferred Stock.  A total of 2,000,000 authorized
shares  of  Preferred  Stock, $0.01  par  value  per  share  (the
"Preferred Stock"), none of which is issued or outstanding.

          (b)   Common  Stock.  A total of 50,000,000  authorized
shares  of  Common  Stock, $0.001 par value, of which  20,001,304
shares  are  issued  and outstanding.  All  of  such  outstanding
shares  are  validly  issued, fully paid and non-assessable.   No
such   outstanding  shares  were  issued  in  violation  of   any
preemptive right.

          (c)   Options, Warrants, Reserved Shares.   Except  for
the  Xircom Stock Option Plan, 1992 Directors Stock Option  Plan,
1994  Employee  Stock Purchase Plan, and the  1995  Stock  Option
Plan,  each  as amended (the "Plans"), there are not  outstanding
any options, warrants, rights (including conversion or preemptive
rights)  or agreements for the purchase or acquisition  from  the
Company  of  any  shares of its capital stock or  any  securities
convertible  into or ultimately exchangeable or  exercisable  for
any  shares of the Company's capital stock.  Except for any stock
repurchase  rights of the Company under the Plans, no  shares  of
the  Company's outstanding capital stock, or stock issuable  upon
exercise,  conversion  or  exchange of any  outstanding  options,
warrants  or rights, or other stock issuable by the Company,  are
subject  to  any  rights  of first refusal  or  other  rights  to
purchase such stock (whether in favor of the Company or any other
person),   pursuant  to  any  agreement,  commitment   or   other
obligation of the Company.

     3.3   Subsidiaries.  The Company does not presently  own  or
control,  directly  or  indirectly, any  interest  in  any  other
corporation,  partnership, trust, joint venture,  association  or
other entity.

     3.4  Due Authorization.  All corporate action on the part of
the  Company, its officers, directors and shareholders  necessary
for   the   authorization,  execution,  delivery  of,   and   the
performance  of  all  obligations  of  the  Company  under,  this
Agreement, the Investor Rights Agreement (as defined below),  and
the  Warrant,  and the authorization, issuance,  reservation  for
issuance  and delivery of all of the Purchased Shares being  sold
under this Agreement and of the Warrant Shares has been taken  or
will   be   taken  prior  to  the  Closing,  and  this  Agreement
constitutes,  and the Investor Rights Agreement and  the  Warrant
when   executed,  will  constitute,  valid  and  legally  binding
obligations  of the Company, enforceable against the  Company  in
accordance with their respective terms, except as may be  limited
by  (i)  applicable  bankruptcy,  insolvency,  reorganization  or
others  laws of general application relating to or affecting  the
enforcement of creditors' rights generally and (ii) the effect of
rules of law governing the availability of equitable remedies.

     3.5  Valid Issuance of Stock.
     
          (a)   The  Purchased  Shares,  when  issued,  sold  and
delivered in accordance with the terms of this Agreement for  the
consideration  provided  for herein, will  be  duly  and  validly
issued,  fully paid and nonassessable.  The Warrant  Shares  have
been  duly  and validly reserved for issuance and, upon issuance,
sale and delivery in accordance with the terms of

<PAGE> 4
     
the  Warrant for the consideration provided for therein, will  be
duly and validly issued, fully paid and nonassessable.

          (b)   Based in part on the representations made by  the
investors in Section 4 hereof, the Purchased Shares, the  Warrant
and  (assuming  no  change  in applicable  law  and  no  unlawful
distribution  of Purchased Shares or the Warrant by the  Investor
or  other  parties)  the Warrant Shares will be  issued  in  full
compliance   with   the  registration  and  prospectus   delivery
requirements of the Securities Act of 1933, as amended (the "1933
Act"), or in compliance with applicable exemptions therefrom, and
the registration and qualification requirements of all applicable
securities laws of the states of the United States.

     3.6  Governmental Consents.  No consent, approval, order  or
authorization  of,  or registration, qualification,  designation,
declaration  or  filing  with,  any  federal,  state   or   local
governmental authority on the part of the Company is required  in
connection with the consummation of the transactions contemplated
by   this   Agreement,  except  for  compliance  with   the   HSR
Requirements   (as  defined  below)  and  the  filing   of   such
qualifications or filings under the 1933 Act and the  regulations
thereunder  and all applicable state securities laws  as  may  be
required in connection with the transactions contemplated by this
Agreement.  All such qualifications and filings will, in the case
of  qualifications, be effective on the Closing and will, in  the
case  of filings, be made within the time prescribed by law.   As
used  herein,  the "HSR Requirements" means compliance  with  the
filing  and other requirements of the Hart-Scott-Rodino Antitrust
Improvements Acts of 1976, as amended (the "HSR Act").

     3.7    Non-Contravention.   The  execution,   delivery   and
performance of this Agreement, the Investor Rights Agreement  and
the  Warrant by the Company, and the consummation by the  Company
of  the transactions contemplated hereby and thereby, do not  and
will  not  (i)  contravene  or  conflict  with  the  Articles  of
Incorporation  or  Bylaws  of  the  Company;  (ii)  constitute  a
material violation of any provision of any federal, state,  local
or  foreign  law  binding upon or applicable to the  Company;  or
(iii)  constitute  a default or require any consent  under,  give
rise  to  any  right of termination, cancellation or acceleration
of,  or to a loss of any benefit to which the Company is entitled
under, or result in the creation or imposition of any lien, claim
or  encumbrance on any assets of the Company under, any  contract
to which the Company is a party or any permit, license or similar
right  relating  to the Company or by which the  Company  may  be
bound or affected in such a manner as would have Material Adverse
Effect.

     3.8   Litigation.   There  is no action,  suit,  proceeding,
claim,  arbitration  or  investigation ("Action")  pending:   (a)
against the Company, its activities, properties or assets or,  to
the  best  of  the  Company's  knowledge,  against  any  officer,
director  or  employee  of the Company in  connection  with  such
officer's, director's or employee's relationship with, or actions
taken  on  behalf  of, the Company, (b) that  seeks  to  prevent,
enjoin,  alter  or  delay the transactions contemplated  by  this
Agreement,  the Investor Rights Agreement or the Warrant.   There
is  no Action pending or, to the best of the Company's knowledge,
threatened,  or  any basis therefor, relating to the  current  or
prior  employment  of  any  of the Company's  current  or  former
employees  or  consultants,  their use  in  connection  with  the
Company's  business of any information, technology or  techniques
allegedly  proprietary to any of their former employers,  clients
or  other parties, or their obligations under any agreements with
prior employers, clients or other parties.

<PAGE> 5

The Company is not a party to or subject to the provisions of any
order,  writ,  injunction, judgment or decree  of  any  court  or
government  agency or instrumentality.  No Action by the  Company
is  currently pending nor does the Company intend to initiate any
Action  which  is  reasonably likely to have a  Material  Adverse
Effect.

     3.9  Invention Assignment and Confidentiality Agreement.  To
the  best  knowledge of the Company, each employee and consultant
or independent contractor of the Company whose duties include the
development  of  products or Intellectual  Property  (as  defined
below),  and  each former employee and consultant or  independent
contractor  whose duties included the development of products  or
Intellectual Property, has entered into and executed an invention
assignment and confidentiality agreement in customary form or  an
employment   or  consulting  agreement  containing  substantially
similar terms.

     3.10 Intellectual Property.
          
          (a)   Ownership or Right to Use.  The Company has  sole
title  to and owns, or is licensed or otherwise possesses legally
enforceable  rights  to use, all patents or patent  applications,
software,  know-how,  registered or unregistered  trademarks  and
service  marks  and  any  applications  therefor,  registered  or
unregistered   copyrights,  trade  names,  and  any  applications
therefor,  trade  secrets  or other confidential  or  proprietary
information  ("Intellectual Property") necessary  to  enable  the
Company  to carry on its business as currently conducted,  except
where  any  deficiency therein would not have a Material  Adverse
Effect.  The Company represents and warrants that it will,  where
the  Company,  in  the exercise of reasonable judgment  deems  it
appropriate,  use reasonable business efforts to  seek  copyright
and  patent  registration,  and  other  appropriate  intellectual
property protection, for Intellectual Property of the Company.

          (b)   Licenses; Other Agreements.  The Company  is  not
currently  subject  to  any  exclusive  licenses  (whether   such
exclusivity is temporary or permanent) to any material portion of
the  Intellectual Property of the Company.  To the  best  of  the
Company's  knowledge, there are not outstanding any  licenses  or
agreements  of any kind relating to any Intellectual Property  of
the Company, except for agreements with OEM's and other customers
of  the  Company  entered  into in the  ordinary  course  of  the
Company's  business.   The Company is not obligated  to  pay  any
royalties or other payments to third parties with respect to  the
marketing, sale, distribution, manufacture, license or use of any
Intellectual Property, except as the Company may be so  obligated
in  the  ordinary course of its business or as disclosed  in  the
Company's SEC Documents (as defined below).

          (c)  No Infringement.  The Company has not violated  or
infringed and is not currently violating or infringing,  and  the
Company  has  not received any communications alleging  that  the
Company (or any of its employees or consultants) has violated  or
infringed,  any  Intellectual Property of  any  other  person  or
entity,  to  the extent that any such violation or  infringement,
either  individually or together with all other  such  violations
and infringements, would have a Material Adverse Effect.

          (d)   Employees and Consultants.  To the  best  of  the
Company's knowledge, no employee of or consultant to the  Company
is in default under any term of any

<PAGE> 6

employment   contract,  agreement  or  arrangement  relating   to
Intellectual  Property  of  the Company  or  any  non-competition
arrangement, other contract, or any restrictive covenant relating
to  the  Intellectual Property of the Company.  The  Intellectual
Property  of  the  Company (other than any Intellectual  Property
duly  acquired  or  licensed from third  parties)  was  developed
entirely by the employees of or consultants to the Company during
the  time they were employed or retained by the Company,  and  to
the  best  knowledge of the Company, at no time during conception
or  reduction  to practice of such Intellectual Property  of  the
Company  were  any such employees or consultants operating  under
any  grant from a government entity or agency or subject  to  any
employment  agreement or invention assignment  or  non-disclosure
agreement  or any other obligation with a third party that  would
materially  and  adversely affect the  Company's  rights  in  the
Intellectual Property of the Company.  Such Intellectual Property
of  the  Company does not, to the best knowledge of the  Company,
include  any  invention or other intellectual  property  of  such
employees or consultants made prior to the time such employees or
consultants  were  employed or retained by the  Company  nor  any
intellectual property of any previous employer of such  employees
or  consultants nor the intellectual property of any other person
or entity.

     3.11 Compliance with Law and Charter Documents.  The Company
is  not  in  violation  or  default  of  any  provisions  of  its
Certificate  of  Incorporation or Bylaws, both  as  amended,  and
except for any violations that would not, either individually  or
in  the  aggregate, have a Material Adverse Effect.  The  Company
has  complied and is in compliance with all applicable  statutes,
laws,  and regulations and executive orders of the United  States
of   America  and  all  states,  foreign  countries   and   other
governmental  bodies  and agencies having jurisdiction  over  the
Company's business or properties.

     3.12  Registration  Rights.   Except  as  provided  in   the
Investor Rights Agreement effective upon the Closing, the Company
is  not  currently subject to any grant or agreement to grant  to
any person or entity any rights (including piggyback registration
rights) to have any securities of the Company registered with the
United  States Securities and Exchange Commission ("SEC") or  any
other governmental authority.

     3.13  Title  to  Property and Assets.   The  properties  and
assets of the Company are owned by the Company free and clear  of
all  mortgages, deeds of trust, liens, charges, encumbrances  and
security interests except for statutory liens for the payment  of
current taxes that are not yet delinquent and liens, encumbrances
and  security  interests  that arise in the  ordinary  course  of
business and do not affect material properties and assets of  the
Company.  With respect to the property and assets it leases,  the
Company  is  in  compliance  with such  leases  in  all  material
respects.

     3.14 SEC Documents.
     
          (a)  The Company has furnished to the Investor prior to
the  date hereof copies of its Annual Report on Form 10-K for the
fiscal year ended September 30, 1996 ("Form 10-K"), and all other
registration  statements, reports and proxy statements  filed  by
the   Company   with  the  Securities  and  Exchange   Commission
("Commission") on or after September 30, 1996 (the Form 10-K  and
such  registration statements, reports and proxy statements,  are
collectively referred to herein as the "SEC Documents").  Each of
the SEC Documents, as of the

<PAGE> 7

respective  date  thereof, did not, and each of the  registration
statements,  reports and proxy statements filed  by  the  Company
with  the  Commission  after the date hereof  and  prior  to  the
Closing  will  not,  as of the date thereof, contain  any  untrue
statement  of  a material fact or omit to state a  material  fact
necessary in order to make the statements made therein, in  light
of  the circumstances under which they were made, not misleading,
except  as  may have been corrected in a subsequent SEC Document.
The Company is not a party to any material contract, agreement or
other  arrangement which was required to have been  filed  as  an
exhibit to the SEC Documents that is not so filed.

          (b)   The  Company has provided the Investor  with  its
audited financial statements (the "Audited Financial Statements")
for  the fiscal year ended September 30, 1996 (the "Balance Sheet
Date").   Since  September 30, 1996, the Company has  duly  filed
with  the  Commission  all registration statements,  reports  and
proxy  statements required to be filed by it under the Securities
Exchange  Act of 1934, as amended (the "Exchange Act"),  and  the
1933  Act.   The  audited  and unaudited  consolidated  financial
statements  of  the Company included in the SEC  Documents  filed
prior  to  the  date  hereof fairly present, in  conformity  with
generally  accepted  accounting principles  ("GAAP")  (except  as
permitted by Form 10-Q) applied on a consistent basis (except  as
may   be  indicated  in  the  notes  thereto),  the  consolidated
financial   position   of  the  Company  and   its   consolidated
subsidiaries as at the date thereof and the consolidated  results
of  their  operations and cash flows for the periods  then  ended
(subject  to  normal year and audit adjustments in  the  case  of
unaudited interim financial statements).

          (c)   Except as and to the extent reflected or reserved
against  in the Company's Audited Financial Statements (including
the  notes  thereto),  the  Company has no  material  liabilities
(whether   accrued  or  unaccrued,  liquidated  or  unliquidated,
secured  or  unsecured, joint or several, due or to  become  due,
vested or unvested, executory, determined or determinable)  other
than:   (i)  liabilities  incurred  in  the  ordinary  course  of
business  since  the Balance Sheet Date that are consistent  with
the  Company's past practices, (ii) liabilities with  respect  to
agreements  to  which the Investor is a party,  and  (iii)  other
Liabilities  that either individually or in the aggregate,  would
not result in a Material Adverse Effect.

     3.15  Absence of Certain Changes Since Balance  Sheet  Date.
Since the Balance Sheet Date, the business and operations of  the
Company  have  been  conducted in the ordinary course  consistent
with past practice, and there has not been:

          (a)   any declaration, setting aside or payment of  any
dividend or other distribution of the assets of the Company  with
respect  to  any shares of capital stock of the Company,  or  any
repurchase, redemption or other acquisition by the Company or any
subsidiary  of  the  Company  of any outstanding  shares  of  the
Company's capital stock;

          (b)   any damage, destruction or loss, whether  or  not
covered  by insurance, except for such occurrences that have  not
resulted,  and are not expected to result, in a Material  Adverse
Effect;

<PAGE> 8

          (c)   any waiver by the Company of a valuable right  or
of  a material debt owed to it, except for such waivers that have
not  resulted,  and  are not expected to result,  in  a  Material
Adverse Effect;

          (d)  any material change or amendment to, or any waiver
of  any material rights under, a material contract or arrangement
by  which the Company or any of its assets or properties is bound
or  subject, except for changes, amendments, or waivers that  are
expressly  provided for or disclosed in this  Agreement  or  that
have  not resulted, and are not expected to result, in a Material
Adverse Effect;

          (e)   any  change  by  the Company  in  its  accounting
principles,  methods or practices or in the manner it  keeps  its
accounting books and records, except any such change required  by
a change in GAAP; and

          (f)   any  other  event or condition of any  character,
except for such events and conditions that have not resulted, and
are not expected to result, in a Material Adverse Effect.

     3.16 Employee Benefits.
     
          (a)   As used in this Section 3.16, the following terms
have the following meanings:  (1) "Benefit Arrangement" means any
material  benefit  arrangement that is not  an  Employee  Benefit
Plan,  including  (i)  each  material  employment  or  consulting
agreement, (ii) each material arrangement providing for insurance
coverage  or workers' compensation benefits, (iii) each  material
bonus   or   deferred  bonus  arrangement,  (iv)  each   material
arrangement  providing  any termination allowance,  severance  or
similar  benefits, (v) each equity compensation plan,  (vi)  each
deferred  compensation plan and (vii) each material  compensation
policy  and  practice  maintained by  the  Company  covering  the
employees, former employees, officers, former officers, directors
and former directors of the Company, and the beneficiaries of any
of  them;  (2) "Benefit Plan" means an Employee Benefit  Plan  or
Benefit  Arrangement;  (3)"COBRA" means the Consolidated  Omnibus
Budget  Reconciliation Act of 1985, as amended, as set  forth  in
Section  4980B  of the Code and Part 6 of Title I of  ERISA;  (4)
"Employee  Benefit  Plan"  means any employee  benefit  plan,  as
defined   in  Section  3(3)  of  ERISA,  that  is  sponsored   or
contributed  to  by  the Company or any ERISA Affiliate  covering
employees  or  former  employees of the  Company;  (5)  "Employee
Pension Benefit Plan" means any employee pension benefit plan, as
defined in Section 3(2) of ERISA that is regulated under Title IV
of  ERISA, other than a Multiemployer Plan; (6) "ERISA" means the
Employee Retirement Income Security Act of 1974, as amended;  (7)
"ERISA Affiliate" of the Company means any other person or entity
that, together with the Company as of the relevant measuring date
under  ERISA,  was  or  is required to be  treated  as  a  single
employer  under Section 414 of the Code; (8)"Group  Health  Plan"
means any group health plan, as defined in Section 5000(b)(l)  of
the Code; (9) "Multiemployer Plan" means a multiemployer plan, as
defined  in  Section  3(37) and 4001(a)(3)  of  ERISA;  and  (10)
"Prohibited  Transaction" means a transaction that is  prohibited
under  Section 4975 of the Code or Section 406 of ERISA  and  not
exempt  under Section 4975 of the Code or Section 408  of  ERISA,
respectively.

<PAGE> 9

          (b)    Neither  the  Company  nor  any  of  its   ERISA
Affiliates sponsors or has sponsored, maintained, contributed to,
or  incurred an obligation to contribute to, any Employee Pension
Benefit  Plan (whether or not terminated).  Neither  the  Company
nor  any  of  its  ERISA Affiliates sponsors  or  has  sponsored,
maintained,   contributed  to,  or  incurred  an  obligation   to
contribute   to,   any  Multiemployer  Plan   (whether   or   not
terminated).

          (c)   No  Employee  Benefit Plan has  participated  in,
engaged  in  or  been a party to any Prohibited Transaction,  and
neither  the  Company  nor any of its ERISA  Affiliates  has  had
asserted  against it any claim for any material tax  or  material
penalty  imposed  under ERISA or the Code  with  respect  to  any
Employee   Benefit  Plan  nor,  to  the  best  of  the  Company's
knowledge,  is  there a basis for any such claim.   To  the  best
knowledge of the Company, no officer, director or employee of the
Company has committed a material breach of any responsibility  or
obligation  imposed upon fiduciaries by Title  I  of  ERISA  with
respect  to  any  Employee Benefit Plan, with  respect  to  which
breach the Company is directly or indirectly liable.

          (d)   Other than routine claims for benefits, there  is
no  material  claim  pending involving any Benefit  Plan  by  any
Person  against such plan or the Company or any ERISA  Affiliate,
nor, to the best of the Company's knowledge, is any such material
claim  threatened.  There is no pending, or to the  best  of  the
Company's knowledge, threatened Proceeding involving any Employee
Benefit  Plan  before  the IRS, the United States  Department  of
Labor or any other governmental authority.

          (e)    No  material  violation  of  any  reporting   or
disclosure  requirement imposed by ERISA or the Code exists  with
respect to any Employee Benefit Plan.

          (f)   Each  Benefit  Plan has been  maintained  in  all
material  respects, by its terms and in operation, in  accordance
with  ERISA  (if  applicable), the Code and all other  applicable
federal,  state,  local and foreign laws.  The  Company  and  its
ERISA Affiliates have made full and timely payment of all amounts
required  to  be (i) contributed under the terms of each  Benefit
Plan and such laws, or (ii) required to be paid as expenses under
such  Benefit Plan.  Each Employee Benefit Plan that is  intended
to  be  qualified  under Section 401(a) of the  Code  either  has
received  a favorable determination letter with respect  to  such
qualified status from the IRS or has filed a request for  such  a
determination  letter with the IRS within the remedial  amendment
period  such  that  such determination of qualified  status  will
apply  from  and  after the effective date of any  such  Employee
Benefit Plan.

          (g)   With respect to any Group Health Plans maintained
by  the  Company or its ERISA Affiliates, whether or not for  the
benefit  of  the Company's employees, the Company and  its  ERISA
Affiliates  have  complied  in all  material  respects  with  the
provisions of COBRA.

          (h)   Except  pursuant  to  the  provisions  of  COBRA,
neither  the  Company  nor  any  ERISA  Affiliate  maintains  any
Employee Benefit Plan that provides benefits described in Section
3(1)  of  ERISA  for  any former employees or  retirees,  or  the
beneficiaries  of  any  of  them, of the  Company  or  its  ERISA
Affiliates.

<PAGE> 10

     3.17 Tax Matters.
     
          (a)  All deficiencies asserted or assessments made as a
result of any examinations by the Internal Revenue Service or any
state, local or foreign taxing authority have been fully paid, or
are  fully  reflected  as a liability in  the  Audited  Financial
Statements.   The  Company has filed on a timely  basis  all  Tax
Returns  required  to have been filed by it and  has  paid  on  a
timely basis all Taxes required to be shown thereon as due.   All
such  Tax  Returns are true, complete and correct in all material
respects.   The  provisions for taxes in  the  Audited  Financial
Statements  have  been determined in accordance  with  GAAP.   No
liability  for Taxes has been incurred by the Company  since  the
Balance  Sheet  Date  other than in the ordinary  course  of  its
business.  No director, officer or employee of the Company having
responsibility  for Tax matters has reason to  believe  that  any
Taxing  authority  has  valid grounds  to  claim  or  assess  any
additional  Tax  with respect to the Company  in  excess  of  the
amounts shown in the Audited Financial Statements for the periods
covered  thereby.  As used in this Agreement, (l)  "Taxes"  means
(x) all federal, state, local and other net income, gross income,
gross  receipts, sales use, ad valorem, value added,  intangible,
unitary,  capital  gain, transfer, franchise,  profits,  license,
lease,  service,  service use, withholding,  backup  withholding,
payroll,   employment,  estimated,  excise,   severance,   stamp,
occupation, premium, property, prohibited transactions,  windfall
or   excess  profits,  customs,  duties  or  other  taxes,  fees,
assessments or charges of any kind whatsoever, together with  any
interest  and  any  penalties, additions  to  tax  or  additional
amounts  with respect thereto, (y) any liability for  payment  of
amounts described in clause (x) whether as a result of transferee
liability,  of  being  a  member of an affiliated,  consolidated,
combined  or  unitary group for any period, or otherwise  through
operation of law and (z) any liability for the payment of amounts
described  in clauses (x) or (y) as a result of any tax  sharing,
tax indemnity or tax allocation agreement or any other express or
implied  agreement to indemnify any other person for  Taxes;  and
the term "Tax" means any one of the foregoing Taxes; and (2) "Tax
Returns"  means all returns, reports, forms or other  information
required to be filed with respect to any Tax.

          (b)   With  respect to all amounts in respect of  Taxes
imposed upon the Company, or for which the Company is or could be
liable,  whether  to taxing authorities (as, for  example,  under
law) or to other persons or entities (as, for example, under  tax
allocation  agreements), and with respect to all taxable  periods
or  portions of periods ending on or before the Closing Date, all
applicable Tax laws and agreements have been fully complied with,
and all such amounts required to be paid by the Company to taxing
authorities or others have been paid.

          (c)   The  Company  has not received  notice  that  the
Internal  Revenue  Service  or any  other  taxing  authority  has
asserted  against  the  Company  any  deficiency  or  claim   for
additional Taxes in connection with any Tax Return, and no issues
have  been  raised  (and  are currently pending)  by  any  taxing
authority in connection with any Tax Return.  The Company has not
received  notice  that  it is or may  be  subject  to  Tax  in  a
jurisdiction in which it has not filed or does not currently file
Tax Returns.

     3.18 Labor Agreements and Actions.
     
          (a)  No collective bargaining agreement exists that  is
binding  on  the  Company,  and no petition  has  been  filed  or
proceedings instituted by an employee or group of

<PAGE> 11

employees with any labor relations board seeking recognition of a
bargaining   representative.   To  the  best  of  the   Company's
knowledge,  no organizational effort is currently being  made  or
threatened  by  or on behalf of any labor union to  organize  any
employees of the Company.

          (b)   There is no labor strike, dispute, slow  down  or
stoppage pending or threatened against or directly affecting  the
Company.  No grievance or arbitration proceeding arising  out  of
or  under any collective bargaining agreement is pending, and  no
claims  therefor exist.  The Company has not received any notice,
and  has  no  knowledge of any threatened labor or  civil  rights
dispute,  controversy  or grievance or  any  other  unfair  labor
practice  proceeding or breach of contact claim  or  action  with
respect to claims of, or obligations to, any employee or group of
employees of the Company.

          (c)    All  individuals  who  are  performing  or  have
performed services for the Company and are or were classified  by
the   Company  as  "independent  contractors"  qualify  for  such
classification under Section 530 of the Revenue Act  of  1978  or
Section 1706 of the Tax Reform Act of 1986, as applicable, except
for  such  instances which would not, in the  aggregate,  have  a
Material Adverse Effect.

     3.19  Real  Property Holding Corporation Status.  Since  its
inception the Company has not been a "United States real property
holding corporation", as defined in Section 897(c)(2) of the U.S.
Internal Revenue Code of 1986, as amended, and in Section  1.897-
2(b)   of   the  Treasury  Regulations  issued  thereunder   (the
"Regulations"),  and  the  Company has filed  with  the  Internal
Revenue  Service all statements, if any, with its  United  States
income tax returns which are required under Section 1.897-2(h) of
the Regulations.

     3.20  Full  Disclosure.  The information contained  in  this
Agreement and the Disclosure Letter with respect to the business,
operations, assets, results of operations and financial condition
of  the  Company,  and  the  transactions  contemplated  by  this
Agreement,  the  Investor Rights Agreement and the  Warrant,  are
true  and  complete in all material respects and do not  omit  to
state any material fact necessary in order to make the statements
therein,  in  light of the circumstances under  which  they  were
made, not misleading.

4.    REPRESENTATIONS, WARRANTIES AND CERTAIN AGREEMENTS  OF  THE
INVESTOR.   The  Investor hereby represents and warrants  to  the
Company, and agrees that:

     4.l   Authorization.  This Agreement and the Investor Rights
Agreement  have  been duly authorized by all necessary  corporate
action  on  the  part of the Investor.  This  Agreement  and  the
Investor  Rights  Agreement constitute the Investor's  valid  and
legally binding obligations, enforceable in accordance with their
respective  terms,  except as may be limited  by  (a)  applicable
bankruptcy, insolvency, reorganization or other laws  of  general
application   relating  to  or  affecting  the   enforcement   of
creditors'  rights generally and (b) the effect of rules  of  law
governing  the availability of equitable remedies.  The  Investor
has  full  corporate  power  and authority  to  enter  into  this
Agreement and the Investor Rights Agreement

<PAGE> 12

     4.2  Purchase for Own Account.  The Purchased Shares and the
Warrant  are being acquired for investment for the Investors  own
account,  not as a nominee or agent, and not with a view  to  the
public  resale or distribution thereof within the meaning of  the
1933  Act, and the Investor has no present intention of  selling,
granting  any  participation  in, or otherwise  distributing  the
same.   The Investor also represents that it has not been  formed
for  the  specific purpose of acquiring the Purchased Shares  and
the Warrant.

     4.3   Disclosure of Information.  The Investor has  received
or  has  had  full  access  to all the information  it  considers
necessary or appropriate to make an informed investment  decision
with  respect  to  the Purchased Shares and  the  Warrant  to  be
purchased  by  the Investor under this Agreement.   The  Investor
further  has  had  an  opportunity to ask questions  and  receive
answers  from  the Company regarding the terms and conditions  of
the offering of the Purchased Shares, the Warrant and the Warrant
Shares  and  to obtain additional information (to the extent  the
Company  possessed such information or could acquire  it  without
unreasonable   effort  or  expense)  necessary  to   verify   any
information  furnished to the investor or to which  the  Investor
had access.  The foregoing, however, does not in any way limit or
modify the representations and warranties made by the Company  in
Article 3.

     4.4   Investment Experience.  The Investor understands  that
the  purchase  of  the Purchased Shares and the Warrant  involves
substantial  risk.   The  Investor:  (a)  has  experience  as  an
investor in securities of companies and acknowledges that  it  is
able  to  fend  for  itself, can bear the economic  risk  of  its
investment in the Purchased Shares and the Warrant and  has  such
knowledge and experience in financial or business matters that it
is  capable of evaluating the merits and risks of this investment
in  the  Purchased Shares and the Warrant and protecting its  own
interests  in connection with this investment and/or  (b)  has  a
preexisting  personal or business relationship with  the  Company
and certain of its officers, directors or controlling persons  of
a  nature  and duration that enables the Investor to be aware  of
the  character,  business acumen and financial  circumstances  of
such persons.

     4.5   Accredited  Investor  Status.   The  Investor  is   an
"accredited   investor"  within  the  meaning  of  Regulation   D
promulgated under the 1933 Act.

     4.6   Restricted Securities.  The Investor understands  that
the  Purchased  Shares and the Warrant to  be  purchased  by  the
Investor hereunder, and any Warrant Shares to be purchased by the
Investor  upon  exercise  of the Warrant,  are  characterized  as
"restricted securities" under the 1933 Act inasmuch as  they  are
being acquired from the Company in a transaction not involving  a
public  offering  and  that under the  1933  Act  and  applicable
regulations  thereunder such securities  may  be  resold  without
registration   under  the  1933  Act  only  in  certain   limited
circumstances.   The Investor is familiar with Rule  144  of  the
SEC,   as  presently  in  effect,  and  understands  the   resale
limitations  imposed thereby and by the 1933 Act.   The  Investor
understands  that the Company is under no obligation to  register
any  of  the securities sold hereunder except as provided in  the
Investor Rights Agreement.

     4.7  Further Limitations on Disposition.  Without in any way
limiting  the  representations  set  forth  above,  the  Investor
further  agrees not to make any disposition of all or any portion
of the Purchased Shares, the Warrant or the Warrant Shares unless
and until:

<PAGE> 13

          (a)   there  is then in effect a registration statement
under  the 1933 Act covering such proposed disposition  and  such
disposition   is  made  in  accordance  with  such   registration
statement; or

          (b)   the  Investor  has notified the  Company  of  the
proposed  disposition  and  has  furnished  the  Company  with  a
statement   of   the  circumstances  surrounding   the   proposed
disposition, and the Investor has furnished the Company,  at  the
expense  of  the Investor or its transferee, with an  opinion  of
counsel,  reasonably  satisfactory  to  the  Company,  that  such
disposition  will  not require registration  of  such  securities
under the 1933 Act.

Notwithstanding the provisions of paragraphs (a) and (b) of  this
Section 4.7, no such registration statement or opinion of counsel
will  be  required for any transfer of any Purchased Shares,  the
Warrant,  or any Warrant Shares in compliance with SEC Rule  144,
Rule  144A  or  Rule  145(d), or if such  transfer  otherwise  is
exempt,  in  the  view of the Company's legal counsel,  from  the
registration requirements of the 1933 Act.

     4.8   Legends.  Certificates evidencing the Purchased Shares
and  the  Warrant Shares will bear each of the legends set  forth
below and the Warrant will bear the legends set forth in (a)  and
(c) below:

          (a)   THE  SECURITIES REPRESENTED HEREBY HAVE NOT  BEEN
REGISTERED  UNDER  THE SECURITIES ACT OF 1933,  AS  AMENDED  (THE
"ACT"),  OR  UNDER THE SECURITIES LAWS OF CERTAIN STATES.   THESE
SECURITIES  ARE  SUBJECT TO RESTRICTIONS ON  TRANSFERABILITY  AND
RESALE  AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS  PERMITTED
UNDER  THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT
TO  REGISTRATION  OR  EXEMPTION THEREFROM.  INVESTORS  SHOULD  BE
AWARE  THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL  RISKS  OF
THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.  THE ISSUER  OF
THESE  SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN  FORM  AND
SUBSTANCE  REASONABLY SATISFACTORY TO THE ISSUER  TO  THE  EFFECT
THAT  ANY  PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH  THE
ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

          (b)   THE  SHARES  EVIDENCED BY  THIS  CERTIFICATE  ARE
SUBJECT  TO CERTAIN RESTRICTIONS SPECIFIED IN A CERTAIN  INVESTOR
RIGHTS  AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL HOLDER  OF
SUCH  SHARES  DATED AS OF JANUARY 13, 1997, A COPY  OF  WHICH  IS
AVAILABLE FOR EXAMINATION AT THE ISSUER'S PRINCIPAL OFFICE.

          (c)   Any  Legends  required by  any  applicable  state
securities laws.

The Legend set forth in Section 4.8(a) hereof will be removed  by
the  Company from any certificate evidencing Purchased Shares  or
the Warrant Shares upon delivery to the Company of an opinion  by
counsel,   reasonably  satisfactory  to  the  Company,   that   a
registration  statement under the 1933 Act is  at  that  time  in
effect  with  respect  to  the legended  security  or  that  such
security

<PAGE> 14

can  be  freely  transferred  in a public  sale  without  such  a
registration  statement being in effect and  that  such  transfer
will not jeopardize the exemption or exemptions from registration
pursuant  to  which the Company issued the Purchased Shares,  the
Warrant or the Warrant Shares.

5.    CONDITIONS TO THE INVESTOR'S OBLIGATIONS AT  CLOSING.   The
obligations  of  the Investor under Sections  l  and  2  of  this
Agreement are subject to the fulfillment or waiver, on or  before
the  Closing  (defined in Section 2.l), of each of the  following
conditions:

     5.1   Representations  and Warranties  True.   Each  of  the
representations  and  warranties  of  the  Company  contained  in
Section  3 will be true and correct on and as of the date  hereof
and on and as of the date of the Closing, except as set forth  in
the  Disclosure Letter, as amended through the Closing, with  the
same  effect  as  though such representations and warranties  had
been made as of the Closing.

     5.2   Performance.   The  Company will  have  performed  and
complied   with   all  agreements,  obligations  and   conditions
contained in this Agreement that are required to be performed  or
complied  with  by  it  on or before the Closing  and  will  have
obtained all approvals, consents and qualifications necessary  to
complete the purchase and sale described herein.

     5.3  Compliance with HSR Requirements.  The HSR Requirements
shall have been complied with.

     5.4    Compliance  Certificate.   The  Company   will   have
delivered to the Investor at the Closing a certificate signed  on
its  behalf  by  its Chief Executive Officer or  Chief  Financial
Officer certifying that the conditions specified in Sections  5.1
and 5.2 hereof have been fulfilled.

     5.5   Securities  Exemptions.  The offer  and  sale  of  the
Purchased Shares and the Warrant to the Investor pursuant to this
Agreement  will  be exempt from the registration requirements  of
the   1933   Act   and  the  registration  and/or   qualification
requirements of all applicable state securities laws.

     5.6   Proceedings  and Documents.  All corporate  and  other
proceedings  in connection with the transactions contemplated  at
the Closing and all documents incident thereto will be reasonably
satisfactory  in  form  and substance to the  Investor,  and  the
Investor  will  have received all such counterpart originals  and
certified  or other copies of such documents as it may reasonably
request.   Such documents shall include (but not be  limited  to)
the following:

          (a)   Certified Charter Documents.  A copy of  (i)  the
Articles  of Incorporation certified as of a recent date  by  the
Secretary  of State of California as a complete and correct  copy
thereof,  and (ii) the Bylaws of the Company (as amended  through
the  date  of  the  Closing) certified by the  Secretary  of  the
Company as true and correct copies thereof as of the Closing.

          (b)   Board  Resolutions.   A copy,  certified  by  the
Secretary  of  the Company, of the resolutions of  the  Board  of
Directors  of  the  Company providing for the  approval  of  this
Agreement  and the Investor Rights Agreement and the issuance  of
the  Purchased  Shares  and the Warrant  and  the  other  matters
contemplated hereby.

<PAGE> 15

     5.7   Opinion  of Company Counsel.  The Investor  will  have
received  an opinion on behalf of the Company, dated  as  of  the
date of the Closing, from Wilson, Sonsini, Goodrich & Rosati,  in
form and substance reasonably satisfactory to the Investor.

     5.8   Warrant  and Investor Rights Agreement.   The  Company
will have issued the Warrant and will have executed and delivered
the  Investor Rights Agreement substantially in the form attached
to this Agreement as Exhibit B (the "Investor Rights Agreement").

     5.9   No  Material Adverse Effect.  Between the date  hereof
and  the  Closing,  there shall not have  occurred  any  Material
Adverse Effect.

6.    CONDITIONS  TO THE COMPANY'S OBLIGATIONS AT  CLOSING.   The
obligations  of the Company to the Investor under this  Agreement
are subject to the fulfillment or waiver on or before the Closing
(defined in Section 2.1), of each of the following conditions:

     6.1     Representations    and   Warranties    True.     The
representations  and  warranties of  the  Investor  contained  in
Section  4 will be true and correct on and as of the date  hereof
and on and as of the date of the Closing with the same effect  as
though  such representations and warranties had been made  as  of
the Closing.

     6.2   Payment  of  Purchase Price.  The Investor  will  have
delivered to the Company the full purchase price of the Purchased
Shares as specified in Section 1.2.

     6.3  Compliance with HSR Requirements.  The HSR Requirements
shall have been complied with.

     6.4   Securities  Exemptions.  The offer  and  sale  of  the
Purchased Shares and the Warrant to the Investor pursuant to this
Agreement  will  be exempt from the registration requirements  of
the   1933   Act   and  the  registration  and/or   qualification
requirements of all applicable state securities laws.

     6.5   Proceedings  and Documents.  All corporate  and  other
proceedings  in connection with the transactions contemplated  at
the Closing and all documents incident thereto will be reasonably
satisfactory  in  form and substance to the Company  and  to  the
Company's  legal counsel, and the Company will have received  all
such  counterpart originals and certified or other copies of such
documents as it may reasonably request.

     6.6   Investor  Rights Agreement.  The  Investor  will  have
executed and delivered the Investor Rights Agreement.

     6.7   Opinion  of Investor Counsel.  The Company  will  have
received  an opinion on behalf of the Investor, dated as  of  the
date  of  the Closing, from Gibson, Dunn & Crutcher,  LLP  and/or
Intel  Corporation  in  house  counsel,  in  form  and  substance
reasonably satisfactory to the Company.

<PAGE> 16

7.   INDEMNIFICATION.

     7.1  Agreement to Indemnify.
     
          (a)   Company Indemnity.  The Investor, its  Affiliates
and   Associates,   and  each  officer,  director,   shareholder,
employer,  representative  and agent  of  any  of  the  foregoing
(collectively,  the  "Investor  Indemnitees")   shall   each   be
indemnified  and held harmless to the extent set  forth  in  this
Section 7 by the Company with respect to any and all Damages  (as
defined below) incurred by any Investor Indemnitee as a proximate
result  of any inaccuracy or misrepresentation in, or breach  of,
any  representation, warranty, covenant or agreement made by  the
Company in this Agreement, the Investor Rights Agreement  or  the
Warrant (including any Exhibits and Schedules hereto).

          (b)   Investor Indemnity.  The Company, its  respective
Affiliates   and   Associates,  and   each   officer,   director,
shareholder,  employer, representative and agent of  any  of  the
foregoing (collectively, the "Company Indemnitees") shall each be
indemnified  and held harmless to the extent set  forth  in  this
Section  7,  by the Investor, in respect of any and  all  Damages
incurred  by any Company Indemnitee as a result of any inaccuracy
or  misrepresentation  in,  or  breach  of,  any  representation,
warranty,  covenant  or agreement made by the  Investor  in  this
Agreement or the Investor Rights Agreement.

          (c)   Equitable  Relief.  Nothing  set  forth  in  this
Section  7  shall  be  deemed to prohibit or limit  any  Investor
Indemnitee's or Company Indemnitee's right at any time before, on
or  after the Closing Date, to seek injunctive or other equitable
relief  for  the failure of any Indemnifying Party to perform  or
comply with any covenant or agreement contained herein.

     7.2   Survival.  All representations and warranties  of  the
Investor  and  the Company contained herein or  in  the  Investor
Rights  Agreement or the Warrant, and all claims of any  Investor
Indemnitee or Company Indemnitee in respect of any inaccuracy  or
misrepresentation in or breach thereof, shall survive the Closing
until  the later of (i) the date of termination of the  Right  of
Participation under the Investor Rights Agreement, and  (ii)  the
third  anniversary of the date of this Agreement,  regardless  of
whether   the   applicable  statute  of  limitations,   including
extensions  thereof, may expire (except to the  extent  any  such
covenant  or agreement shall expire by its terms).  All covenants
and  agreements of the Investor and the Company contained  herein
or  in the Investor Rights Agreement or the Warrant shall survive
the Closing in perpetuity (except to the extent any such covenant
or  agreement  shall expire by its terms).   All  claims  of  any
Investor  Indemnitee  or Company Indemnitee  in  respect  of  any
breach  of such covenants or agreements shall survive the Closing
until  the  expiration of two years following  the  non-breaching
party's obtaining actual knowledge of such breach.

     7.3  Claims for Indemnification.  If any Investor Indemnitee
or  Company Indemnitee (an "Indemnitee") shall believe that  such
Indemnitee  is  entitled  to  indemnification  pursuant  to  this
Section  7 in respect of any Damages, such Indemnitee shall  give
the appropriate Indemnifying Party (which for purposes hereof, in
the case of an Investor Indemnitee, means the Company, and in the
case  of a Company Indemnitee, means the Investor) prompt written
notice  thereof.  Any such notice shall set forth  in  reasonable
detail and to the extent then known the basis

<PAGE> 17

for   such  claim  for  indemnification.   The  failure  of  such
Indemnitee  to  give  notice  of any  claim  for  indemnification
promptly  shall not adversely affect such Indemnitee's  right  to
indemnity  hereunder  except  to the  extent  that  such  failure
adversely  affects the right of the Indemnifying Party to  assert
any  reasonable  defense  to such claim.   Each  such  claim  for
indemnity shall expressly state that the Indemnifying Party shall
have only the twenty (20) business day period referred to in  the
next  sentence  to dispute or deny such claim.  The  Indemnifying
Party  shall have twenty (20) business days following its receipt
of  such  notice either (a) to acquiesce in such claim by  giving
such  Indemnitee written notice of such acquiescence  or  (b)  to
object  to the claim by giving such Indemnitee written notice  of
the  objection.   If Indemnifying Party does not  object  thereto
within  such  twenty  (20) business day period,  such  Indemnitee
shall  be  entitled to be indemnified for all Damages  reasonably
and  proximately incurred by such Indemnitee in respect  of  such
claim.   If  the Indemnifying Party objects to such  claim  in  a
timely  manner,  the  senior management of the  Company  and  the
Investor shall meet to attempt to resolve such dispute.   If  the
dispute cannot be resolved by the senior management either  party
may  make  a  written  demand for formal dispute  resolution  and
specify  therein  the scope of the dispute.  Within  thirty  days
after  such written notification, the parties agree to  meet  for
one   day   with  an  impartial  mediator  and  consider  dispute
resolution alternatives other than litigation.  If an alternative
method  of  dispute resolution is not agreed upon  within  thirty
days  after  the  one  day  mediation,  either  party  may  begin
litigation proceedings.  Nothing in this section shall be  deemed
to require arbitration.

     7.4   Defense of Claims.  In connection with any claim  that
may give rise to indemnity under this Section 7 resulting from or
arising out of any claim or Proceeding against an Indemnitee by a
person  or  entity  that is not a party hereto, the  Indemnifying
Party  may  but shall not be obligated to (unless such Indemnitee
elects  not  to  seek indemnity hereunder for such  claim),  upon
written notice to the relevant Indemnitee, assume the defense  of
any  such  claim  or  proceeding if the Indemnifying  Party  with
respect  to  such  claim  or  Proceeding  acknowledges   to   the
Indemnitee the Indemnitee's right to indemnity pursuant hereto to
the  extent provided herein (as such claim may have been modified
through   written  agreement  of  the  parties   or   arbitration
hereunder)   and  provides  assurances,  satisfactory   to   such
Indemnitee, that the Indemnifying Party will be financially  able
to satisfy such claim to the extent provided herein if such claim
or  Proceeding  is  decided adversely;  provided,  however,  that
nothing  set  forth  herein  shall  be  deemed  to  require   the
Indemnifying Party to waive any crossclaims or counterclaims  the
Indemnifying  Party  may have against the Indemnified  Party  for
damages.   The  Indemnified Party shall  be  entitled  to  retain
separate  counsel,  reasonably  acceptable  to  the  Indemnifying
Party,  if  the  Indemnified Counsel shall  determine,  upon  the
written  advice of counsel, that an actual or potential  conflict
of  interest  exists  between  the  Indemnifying  Party  and  the
Indemnified  Party  in  connection  with  such  Proceeding.   The
Indemnifying Party shall be obligated to pay the reasonable  fees
and   expenses  of  such  separate  counsel  to  the  extent  the
Indemnified   Party  is  entitled  to  indemnification   by   the
Indemnifying Party with respect to such claim or Proceeding under
this  Section 7.4.  If the Indemnifying Party assumes the defense
of  any  such  claim or Proceeding, the Indemnifying Party  shall
select  counsel  reasonably  acceptable  to  such  Indemnitee  to
conduct  the defense of such claim or Proceeding, shall take  all
steps necessary in the defense or settlement thereof and shall at
all  times diligently and promptly pursue the resolution thereof.
If  the Indemnifying Party shall have assumed the defense of  any
claim  or  Proceeding in accordance with this  Section  7.4,  the
Indemnifying Party shall be authorized to consent to a settlement
of, or

<PAGE 18>

the  entry  of  any  judgment arising from,  any  such  claim  or
Proceeding,  with  the prior written consent of such  Indemnitee,
not  to  be  unreasonably withheld; provided, however,  that  the
Indemnifying  Party  shall pay or cause to be  paid  all  amounts
arising out of such settlement or judgment concurrently with  the
effectiveness  thereof; provided, further, that the  Indemnifying
Party  shall not be authorized to encumber any of the  assets  of
any Indemnitee or to agree to any restriction that would apply to
any  Indemnitee  or  to  its conduct of business;  and  provided,
further,  that  a  condition to any such settlement  shall  be  a
complete   release  of  such  Indemnitee  and   its   Affiliates,
directors,  officers, employees and agents with respect  to  such
claim,    including   any   reasonably   foreseeable   collateral
consequences  thereof.   Such Indemnitee  shall  be  entitled  to
participate in (but not control) the defense of any such  action,
with  its  own  counsel and at its own expense.  Each  Indemnitee
shall,  and  shall  cause  each  of  its  Affiliates,  directors,
officers,  employees  and  agents to, cooperate  fully  with  the
Indemnifying  Party  in the defense of any  claim  or  Proceeding
being defended by the Indemnifying Party pursuant to this Section
7.4.   If  the Indemnifying Party does not assume the defense  of
any  claim  or Proceeding resulting therefrom in accordance  with
the terms of this Section 7.4, such Indemnitee may defend against
such   claim  or  Proceeding  in  such  manner  as  it  may  deem
appropriate,  including settling such claim or  proceeding  after
giving  notice  of the same to the Indemnifying  Party,  on  such
terms   as  such  Indemnitee  may  deem  appropriate.    If   any
Indemnifying  Party seeks to question the manner  in  which  such
Indemnitee defended such claim or Proceeding or the amount of  or
nature of any such settlement, such Indemnifying Party shall have
the  burden to prove by a preponderance of the evidence that such
Indemnitee  did  not  defend  such  claim  or  Proceeding  in   a
reasonably prudent manner.

     7.5   Certain Definitions.  As used in this Section  7,  (a)
"Affiliate"  means,  with respect to any person  or  entity,  any
person  or  entity directly or indirectly controlling, controlled
by  or  under direct or indirect common control with  such  other
person or entity; (b) "Associate" means, when used to indicate  a
relationship with any person or entity, (l) any other  person  or
entity  of  which  such  first person or entity  is  an  officer,
director or partner or is, directly or indirectly, the beneficial
owner  of  ten  percent  (10%) or more of  any  class  of  equity
securities,  membership interests or other  comparable  ownership
interests issued by such other person or entity, (2) any trust or
other  estate  in  which such first person or entity  has  a  ten
percent  (10%)  or more beneficial interest or as to  which  such
first  person  or  entity  serves as  trustee  or  in  a  similar
fiduciary capacity, and (3) any relative or spouse of such  first
person  or  entity who has the same home as such first person  or
entity  or  who is a director or officer of such first person  or
entity;  (c)  "Damages"  means all demands,  claims,  actions  or
causes  of action, assessments, losses, damages, costs, expenses,
liabilities, judgments, awards, fines, response costs, sanctions,
taxes,   penalties,  charges  and  amounts  paid  in  settlement,
including (1) interest on cash disbursements in respect of any of
the  foregoing at the prime rate of Bank of America, NT & SA,  as
in  effect from time to time, compounded quarterly, from the date
each  such  cash  disbursement is made until the date  the  party
incurring  such cash disbursement shall have been indemnified  in
respect thereof, and (2) reasonable out-of-pocket costs, fees and
expenses  (including  reasonable  costs,  fees  and  expenses  of
attorneys,  accountants and other agents  of,  or  other  parties
retained by, such party), and (d) "Proceeding" means any  action,
suit, hearing, arbitration, audit, proceeding (public or private)
or  investigation that is brought or initiated by or against  any
federal,  state, local or foreign governmental authority  or  any
other person or entity.

<PAGE> 19

     8.1   Successors and Assigns.  The terms and  conditions  of
this  Agreement will inure to the benefit of and be binding  upon
the respective successors and assigns of the parties.

     8.2   Governing Law.  This Agreement will be governed by and
construed  under the internal laws of the State of California  as
applied to agreements among California residents entered into and
to  be performed entirely within California, without reference to
principles of conflict of laws or choice of laws.

     8.3  Counterparts.  This Agreement may be executed in two or
more counterparts, each of which will be deemed an original,  but
all   of  which  together  will  constitute  one  and  the   same
instrument.

     8.4   Headings.   The  headings and captions  used  in  this
Agreement  are  used  for convenience only  and  are  not  to  be
considered  in  construing or interpreting this  Agreement.   All
references  in  this Agreement to sections, paragraphs,  exhibits
and  schedules will, unless otherwise provided, refer to sections
and paragraphs hereof and exhibits and schedules attached hereto,
all  of  which exhibits and schedules are incorporated herein  by
this reference.

     8.5   Notices.  Any notice required or permitted under  this
Agreement  will  be  given in writing, shall  be  effective  when
received,  and  shall  in  any  event  be  deemed  received   and
effectively  given  upon personal delivery to  the  party  to  be
notified or three (3) business days after deposit with the United
States  Post  Office,  by registered or certified  mail,  postage
prepaid,  or one (1) business day after deposit with a nationally
recognized  courier service such as Fedex for next  business  day
delivery,  or  one  (1) business day after  facsimile  with  copy
delivered  by registered or certified mail, postage  prepaid  and
addressed  to  the party to be notified at the address  indicated
for  such  party on the signature page hereof or  at  such  other
address as the Investor or the Company may designate by giving at
least  ten  (10)  days advance written notice  pursuant  to  this
Section 8.5.

     8.6   No  Finder's  Fees.   Each party  represents  that  it
neither is nor will be obligated for any finder's or broker's fee
or  commission in connection with this transaction other than the
fees  of  Goldman  Sachs & Co. to be paid by  the  Company.   The
Investor  will indemnify and hold harmless the Company  from  any
liability for any commission or compensation in the nature  of  a
finders'  or broker's fee for which the Investor or  any  of  its
officers,  partners, employees or consultants, or representatives
is responsible.  The Company will indemnify and hold harmless the
Investor from any liability for any commission or compensation in
the nature of a finder's or broker's fee for which the Company or
any  of its officers, employees or consultants or representatives
is responsible.

     8.7   Amendments and Waivers.  This Agreement may be amended
and  the  observance of any term of this Agreement may be  waived
(either  generally  or  in  a  particular  instance  and   either
retroactively or prospectively), only with the written consent of
the  Company  and the holders of Purchased Shares and/or  Warrant
Shares  representing at least a majority of the  total  aggregate
number  of  Purchased Shares and Warrant Shares then  outstanding
(excluding  any of such shares that have been sold to the  public
pursuant to SEC Rule 144 or otherwise).  Any

<PAGE> 20

amendment or waiver effected in accordance with this Section  8.7
will  be  binding  upon  the  Investor,  the  Company  and  their
respective successors and assigns.

     8.8   Severability.  If any provision of this  Agreement  is
held  to  be  unenforceable under applicable law, such  provision
will  be  excluded  from this Agreement and the  balance  of  the
Agreement  will  be  interpreted as if  such  provision  were  so
excluded and will be enforceable in accordance with its terms.

     8.9   Entire Agreement.  This Agreement, together  with  all
Exhibits  and schedules hereto, constitutes the entire  agreement
and  understanding  of the parties with respect  to  the  subject
matter  hereof  and  supersedes any and all  prior  negotiations,
correspondence, agreements, understandings duties or  obligations
between the parties with respect to the subject matter hereof.

     8.10  Further Assurances.  From and after the date  of  this
Agreement  upon the request of the Investor or the  Company,  the
Company   and   the  Investor  will  execute  and  deliver   such
instruments,  documents or other writings as  may  be  reasonably
necessary or desirable to confirm and carry out and to effectuate
fully the intent and purposes of this Agreement.

     8.11  Meaning  of Include and Including.  Whenever  in  this
Agreement the word "include" or "including" is used, it shall  be
deemed  to  mean  "include,  without limitation"  or  "including,
without  limitation,"  as  the case  may  be,  and  the  language
following  "include" or "including" shall not be  deemed  to  set
forth an exhaustive list.

     8.12 Fees, Costs and Expenses.  All fees, costs and expenses
(including attorneys' fees and expenses) incurred by either party
hereto  in  connection  with  the  preparation,  negotiation  and
execution  of  this Agreement, the Investor Rights Agreement  and
the Warrant and the consummation of the transactions contemplated
hereby   and   thereby,   shall  be  the   sole   and   exclusive
responsibility of such party.

[The remainder of this page is intentionally left blank.]

<PAGE> 21

IN  WITNESS  WHEREOF,  the  parties  hereto  have  executed  this
Agreement as of the date first above written.

XIRCOM, INC.                        INTEL CORPORATION
                                    
By:  /s/Dirk I. Gates               By:  /s/Arvind Sodhani
                                    
Name:  Dirk I. Gates                Name:  Arvind Sodhani
                                    
Title:    Chairman, President       Title:    Vice President and
          and Chief Executive                 Treasurer
          Officer                   
                                    
Date Signed: January 13, 1997       Date Signed: January 13, 1997
                                    
Address:  2300 Corporate            Address:  2200 Mission
          Center Drive                        College Boulevard
          Thousand Oaks,                      Santa Clara,
          California 91320                    California 95052
                                    
Telephone No: (805)376-9300         Telephone No: (408)765-1240
                                    
Facsimile No: (805)376-9120         Facsimile No: (408)765-1611

 [Signature Page to Common Stock and Warrant Purchase Agreement]
                                
<PAGE> 22

           COMMON STOCK AND WARRANT PURCHASE AGREEMENT
                                
                        LIST OF EXHIBITS
                                
Exhibit A -    Form of Warrant

Exhibit B -    Form of Investor Rights Agreement







                            EXHIBIT 2
                                
                   WARRANT TO PURCHASE SHARES
                                
                         OF COMMON STOCK
                                
                               OF
                                
                          XIRCOM, INC.
                                
<PAGE>

THE  SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER
THE  SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR UNDER THE
SECURITIES LAWS OF CERTAIN STATES.  THESE SECURITIES ARE  SUBJECT
TO  RESTRICTIONS ON TRANSFERABILITY AND RESALE  AND  MAY  NOT  BE
TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT  AND  THE
APPLICABLE  STATE  SECURITIES LAWS, PURSUANT TO  REGISTRATION  OR
EXEMPTION THEREFROM.  INVESTORS SHOULD BE AWARE THAT THEY MAY  BE
REQUIRED  TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT  FOR  AN
INDEFINITE  PERIOD OF TIME.  THE ISSUER OF THESE  SECURITIES  MAY
REQUIRE  AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY
TO  THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE
IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES
LAWS.

                                 Void after 5:00 p.m.,
                                 Pacific Time
                                 on February 27, 2002
                                 


           WARRANT TO PURCHASE SHARES OF COMMON STOCK
                               OF
                          XIRCOM, INC.
                                


Initial Number of Shares:  1,509,903 shares
Date of Grant:             February 28, 1997
Expiration Date:           February 27, 2002
                           
THIS  CERTIFIES THAT, for value received pursuant to that certain
Common  Stock and Warrant Purchase Agreement dated as of  January
13,  1997  (the "Purchase Agreement), Intel Corporation  and  any
person   to  whom  the  interest  in  this  Warrant  is  lawfully
transferred pursuant to the terms and conditions set forth herein
(the original holder hereof and such transferees are referred  to
hereinafter as the "Holder") is entitled to purchase, at any time
and  from  time to time after the date hereof, up  to  the  above
number  (as adjusted pursuant to Section 2 hereof) of fully  paid
and  nonassessable shares of the Common Stock (the  "Shares")  of
Xircom,  Inc., a California corporation (the "Company"),  at  the
applicable  Per Share Exercise Price as set forth in Section  1.1
hereof,  subject  to  the  provisions  and  upon  the  terms  and
conditions set forth herein.

This Warrant is subject to the following terms and conditions:

1.   EXERCISE.

      1.1   Per  Share  Purchase Price.  The "Per Share  Purchase
Price"  at  which this Warrant may be exercised shall be  as  set
forth  in  the following table, subject to adjustment as provided
in Section 2 hereof:

<PAGE> 2

                Date of Exercise                    Price
                ----------------                    -----
From February 28, 1997 through February 27, 1998  $22.8525
                                                  
From February 28, 1998 through February 27, 1999  $27.0075
                                                  
From February 28, 1999 through February 27, 2002  $31.1625
                                                  
      1.2  Expiration.  This Warrant shall expire and be canceled
in  its entirety on the Expiration Date set forth above and  must
be  exercised,  if  at  all,  on or before  the  Expiration  Date
(subject only to the provisions of Section 1.6 below).

     1.3  Exercise.

          (a)  The purchase right represented by this Warrant may
be  exercised by the Holder, in whole or in part, for up  to  the
total number of shares then exercisable, by the surrender of this
Warrant  (with  the Common Stock Warrant Notice of Exercise  form
attached hereto as Annex I duly executed) at the principal office
of the Company and by the payment to the Company in cash (by wire
transfer),  in  an  amount equal to the then applicable  Purchase
Price  Per  Share multiplied by the number of Shares  then  being
purchased.

           (b)  In lieu of exercising this Warrant by payment  of
cash,  when  permitted  by  law and applicable  regulations,  the
Holder  may  pay  such exercise price through a "same  day  sale"
commitment from the Holder and a broker-dealer that is  a  member
of  the  National  Association of Securities  Dealers  (an  "NASD
Dealer")  whereby the Holder irrevocably elects to  exercise  the
Warrant and to sell a portion of the Shares so purchased  to  pay
for  the  exercise price and whereby the NASD Dealer  irrevocably
commits upon receipt of such Shares to forward the exercise price
directly to the Company.

           (c)  In lieu of exercising this Warrant by payment  of
cash  or by payment through a same day sale, the Holder may elect
to  receive, without the payment by the Holder of any  additional
consideration,  a number of shares (rounded down to  the  nearest
whole  share) equal to the value of this Warrant or  any  portion
hereof  by the surrender of this Warrant or such portion  to  the
Company  (the  "Net  Exercise"),  with  the  net  issue  election
initialed in the Common Stock Warrant Notice of Exercise  annexed
hereto  duly  executed, at the office of the Company.   Thereupon
the  Company  will issue to the Holder such number of  shares  of
Common  Stock  of the Company as is computed using the  following
formula.

<PAGE> 3

                           X = Y (A-B)
                               -------
                                   A

where X =  the  number of shares of Common Stock to be issued  to
           the  Holder  upon  the Net Exercise pursuant  to  this
           Section 1.3;
           
Y =        the  number of Shares exercised under this Warrant for
           which the net issue election is made pursuant to  this
           Section  1.3  (upon such Net Exercise, the  number  of
           shares  subject to further exercise under this Warrant
           shall be reduced by this number);
           
A =        the  Market Price (as defined below) of one  share  of
           the  Company's Common Stock on the date the net  issue
           election is made pursuant to this Section 1.3; and
           
B =        the  Per  Share  Purchase Price in effect  under  this
           Warrant  on  the date the net issue election  is  made
           pursuant to this Section 1.3.
           
For  purposes of this Section 1.3, "Market Price" means, as to  a
share of Common Stock, the average of the closing prices of sales
on  all  domestic securities exchanges on which the Common  Stock
may at the time be listed, or, if there have been no sales on any
such  exchange  on any day, the average of the  highest  bid  and
lowest asked prices on all such exchanges at the end of such day,
or,  if on any day the Common Stock is not so listed, the average
of  the  representative bid and asked prices quoted in the Nasdaq
National Market as of 4:00 P.M., New York time, on such day,  or,
if  on  any  day  the Common Stock is not quoted  in  the  Nasdaq
National Market, the average of the highest bid and lowest  asked
prices  on  such day in the domestic over-the-counter  market  as
reported by the National Quotation Bureau, Incorporated,  or  any
similar successor organization, in each such case averaged over a
period of thirty (30) Trading Days immediately preceding the date
the net issue election or other exercise is made pursuant to this
Section  1.3;  provided, however, that if  the  Common  Stock  is
listed  on  any  domestic securities exchange the  term  "Trading
Days"  as used in this sentence means days on which such exchange
is  open  for  trading.  If at any time the Common Stock  is  not
listed  on  any  domestic securities exchange or  quoted  in  the
Nasdaq  National Market or the domestic over-the counter  market,
the  "Market  Price"  shall be the fair value thereof  determined
jointly by the Company and the Holder; provided, however, that if
such  parties  are unable to reach agreement within fifteen  (15)
business  days  following written notice from the Holder  to  the
Company  setting forth the Holder's determination  of  such  fair
value,  such  fair  value  shall be determined  by  an  appraiser
jointly   selected   by  the  Company  and   the   Holder.    The
determination of such appraiser shall be final and binding on the
Company  and  the  Holder,  and the fees  and  expenses  of  such
appraiser shall be paid by the Company.

     1.4  Limitations on Exercise.  The exercise of this Warrant,
and the issuance of the Shares will be subject to and conditioned
upon compliance by the Company and the Holder with all applicable
state  and  federal laws and regulations and with all  applicable
requirements of any stock exchange or automated quotation  system
on  which  the Company's common stock may be listed or quoted  at
the time of such issuance or transfer.  The Company shall, at its
sole  cost and expense, use its reasonable best efforts  to  make
all filings, notices and applications required

<PAGE> 4

by  the  Company  (excluding filings,  notices  and  applications
required by the Holder), and take all other actions necessary  to
permit  the  exercise  of this Warrant  by  the  Holder  and  the
issuance  of  the  Shares to the Holder,  and  the  Holder  shall
cooperate  with  all  reasonable  requests  of  the  Company   in
connection  therewith.  This Warrant may not be exercised  as  to
fewer  than 50,000 Shares unless it is exercised as to all Shares
as to which the Warrant is then exercisable.

      1.5  Issuance of New Warrant.  In the event of any exercise
of  the  purchase right represented by this Warrant, certificates
for  the  Shares  so purchased will be delivered  to  the  Holder
within four (4) business days after receipt of such payment  and,
unless  this Warrant has been fully exercised or has  expired,  a
new  Warrant representing the portion of the Shares, if any, with
respect  to which this Warrant will not then have been  exercised
will also be issued to the Holder within a reasonable time.

     1.6  Hart Scott-Rodino Compliance.

           (a)  The Company hereby acknowledges that the exercise
of  this  Warrant  by Holder may subject the Company  and/or  the
Holder  to  the  filing  requirements of  the  Hart-Scott  Rodino
Antitrust Improvements Act of 1976 (the "HSR Act") and  that  the
Holder may be prevented from closing the exercise of this Warrant
until  the expiration or early termination of all waiting periods
imposed by, and compliance with all other requirements under, the
HSR  Act  ("HSR  Requirements").  If on or before the  Expiration
Date, the Holder (i) has sent the Common Stock Warrant Notice  of
Exercise to the Company, (ii) has irrevocably elected to exercise
this  Warrant for the number of Shares specified in  such  notice
subject  only to compliance with the HSR Requirements, and  (iii)
the  Holder  has not been able to complete the exercise  of  this
Warrant  prior to the Expiration Date solely because of  the  HSR
Requirements, then, for so long as the Holder actively  continues
in  its  effort to comply with the HSR Requirements,  the  Holder
shall  be  entitled  to complete the process of  exercising  this
Warrant  for  such  number  of  Shares  in  accordance  with  the
procedures  contained  herein  notwithstanding  the   fact   that
completion of the exercise of this Warrant would take place after
the  Expiration Date.  If an exercise by Holder is subject to HSR
Requirements, the amount payable upon such exercise shall be paid
to  the  Company  within five (5) business days of  the  Holder's
receiving  written  notice  the expiration  or  notice  of  early
termination of, or compliance with, all HSR Requirements.

            (b)   The  Company  and  the  Holder  shall  use  all
reasonable efforts to comply with the HSR Requirements; provided,
however,  that neither the Company nor the Holder shall be  under
any  obligation to comply with any request or requirement imposed
by  the  Federal Trade Commission (the "FTC"), the Department  of
Justice   ("DofJ")  or  any  other  governmental   authority   in
connection with their compliance with the HSR Requirements if the
Company  or the Holder reasonably determines that such compliance
is  unduly  burdensome.  Without limiting the generality  of  the
foregoing, neither the Company nor the Holder shall be  obligated
to  comply with any request by, or requirement of, the  FTC,  the
DofJ  or  any  other  governmental  authority,  that  such  party
determines is unduly burdensome:  (i) to disclose information the
Company  or  the  Holder, as the case may  be,  desires  to  keep
confidential;  (ii) to dispose or any assets  or  operations;  or
(iii) to comply with any restriction on the manner in which  they
conduct  their  respective operations.  In  the  event  that  the
Company   shall  elect  not  to  comply  with  any  of  the   HSR
Requirements  pursuant to the immediately preceding sentence,  it
shall be

<PAGE> 5

obligated  to  pay to the Holder within sixty (60) business  days
following written election from the Holder an amount equal to the
difference between:  (1) the Market Price as of the date  of  the
Common Stock Warrant Notice of Exercise, multiplied by the number
of  Shares  to which such notice relates; and (2) the  Per  Share
Purchase Price, multiplied by the number of such Shares.

2.   ADJUSTMENT OF NUMBER OF SHARES AND PER SHARE PURCHASE PRICE.
The  number  of  Shares  purchasable upon the  exercise  of  this
Warrant,  and  the Per Share Purchase Price, will be  subject  to
adjustment from time to time as provided in this Section 2:

      2.1   Subdivision or Combination of Common Stock.   If  the
Company  at  any  time  subdivides (by  any  stock  split,  stock
dividend,  recapitalization or otherwise) its outstanding  shares
of  Common  Stock into a greater number of shares, the Per  Share
Purchase  Price  in effect immediately prior to such  subdivision
shall  be  proportionately reduced and the number  of  shares  of
Common  Stock obtainable upon exercise of this Warrant  shall  be
proportionately increased.  If the Company at any  time  combines
(by  reverse stock split or otherwise) its outstanding shares  of
Common  Stock  into  a smaller number of shares,  the  Per  Share
Purchase  Price  in effect immediately prior to such  combination
shall  be  proportionately increased and the number of shares  of
Common  Stock obtainable upon exercise of this Warrant  shall  be
proportionately decreased.

     2.2  Stock Dividends.  If the Company at any time while this
Warrant  remains  outstanding  and  unexpired  pays  a  dividend,
without  receipt  of consideration therefor, to  the  holders  of
Common  Stock payable in shares of Common Stock, Preferred Stock,
other  capital  stock  or other securities  convertible  into  or
exchangeable  for Common Stock, Preferred Stock or other  capital
stock  ("Convertible Securities"), or options to purchase  Common
Stock,  Preferred  Stock,  other  capital  stock  or  Convertible
Securities ("Options"), other than any event for which adjustment
is  made  pursuant to Section 2.1 hereof, the Holder shall,  upon
exercise  of this Warrant be entitled to receive, in addition  to
the  number of Shares receivable thereupon, the amount of  Common
Stock,   Preferred   Stock,  other  capital  stock,   Convertible
Securities or Options that such Holder would have received had it
been  Holder  of record of such Shares as of the  date  on  which
holders  of  Common Stock received or became entitled to  receive
such  additional shares of Common Stock, Preferred  Stock,  other
capital stock, Convertible Securities or Options.  Any adjustment
under  this Section 2.2 will become effective on the record  date
or, if there is no record date, on the date of issuance.

      2.3   Reorganization, Reclassifications, Mergers or  Sales.
Any     recapitalization,    reorganization,    reclassification,
consolidation, merger, sale of all or substantially  all  of  the
Company's   assets  or  other  transaction  (including,   without
limitation,  any  Corporate Event (as  defined  in  the  Investor
Rights Agreement)), in each case that is effected in such  a  way
that  the holders of Common Stock are entitled to receive (either
directly  or  upon subsequent liquidation) stock,  securities  or
assets,  or a combination thereof, with respect to or in exchange
for  Common  Stock is referred to herein as an "Organic  Change."
Prior  to the consummation of any Organic Change, other than  any
event for which adjustment is made pursuant to Section 2.1 or 2.2
hereof,  the  Company  shall, subject  to  Section  1.2(c),  make
appropriate   provision   (in  form  and   substance   reasonably
satisfactory  to  the  Holder) to ensure that  the  Holder  shall
thereafter  have the right to acquire and receive, upon  exercise
of this Warrant in accordance with its terms and upon payment

<PAGE> 6

of  the Per Share Exercise Price then in effect, in lieu of  each
Share  of  Common  Stock immediately theretofore  acquirable  and
receivable  upon  the exercise of this Warrant,  such  shares  of
stock,  securities  or assets as may be issued  or  payable  with
respect  to  each  share of Common Stock immediately  theretofore
acquirable  and receivable upon exercise of the Warrant  had  the
Warrant  been exercised immediately prior to such Organic Change.
The  Company shall not effect any such consolidation,  merger  or
sale,  unless  prior to the consummation thereof,  the  successor
entity  (if  other than the Company) resulting from consolidation
or merger or the entity purchasing such assets assumes by written
instrument, the obligation to deliver to such Holder such  shares
of  stock,  securities  or  assets as,  in  accordance  with  the
foregoing provisions, such Holder may be entitled to acquire.

     2.4  Certain Events.  If (i) any event occurs of a type that
would  have  an effect on the rights granted under  this  Warrant
similar  to  the  effect  of any event  described  by  the  other
provisions of this Section 2 and (ii) such event is not expressly
provided  for  by  such  other  provisions  (including,   without
limitation,  the  granting of stock appreciation rights,  phantom
stock  rights  or  other rights with equity  features),  then  an
appropriate  adjustment in the Per Share Purchase Price  and  the
number of shares of Common Stock obtainable upon exercise of this
Warrant so as to protect the rights of the Holder shall be made.

     2.5  Notices.

          (a)  Within ten (10) business days of any adjustment of
the  Per  Share  Purchase Price, the Company shall  give  written
notice  thereof  to the Holder, setting forth and  certifying  in
reasonable  detail  the  facts causing such  adjustment  and  the
calculation  of  such  adjustment.  The  Company  will  give  due
consideration  to,  and  consult  with  counsel  regarding,   any
objection  the Holder may have to the matters described  in  such
notice,  and  will  make any corrections to  such  notice  deemed
necessary to conform with the terms of this Warrant.

           (b)   The  Company shall give written  notice  to  the
Holder at least ten (10) business days prior to the date on which
the  Company closes its books or takes a record (A) with  respect
to  any  dividend  or distribution (cash or otherwise)  upon  the
Common  Stock,  (B) with respect to any pro rata subscription  or
other  offer  to holders of Common Stock and (C) for  determining
rights to vote with respect to any Organic Change, dissolution or
liquidation.

           (c)  The Company shall also give written notice to the
Holder at least ten (10) business days prior to the date on which
any  Organic Change, dissolution or liquidation shall take place,
and,  for  so  long as Intel Corporation or any of  its  Majority
Owned  Subsidiaries holds the Warrant or any portion thereof,  at
least three (3) business days prior to the date it enters into an
agreement to do any of the foregoing.

3.   TRANSFERABILITY OF WARRANT.

       3.1    Majority  Owned  Subsidiary.   A  "Majority   Owned
Subsidiary"  shall  mean a subsidiary of which Intel  Corporation
beneficially owns, either directly or indirectly, at least 50% of
the voting securities.

<PAGE> 7

      3.2   Institutional Investor.  An "Institutional  Investor"
shall  mean any person considered to be an "accredited  investor"
under  Rule 501(a)(1) of Regulation D promulgated under the  Act;
provided,  however,  that  "Institutional  Investor"  shall   not
include any person or affiliate of a person that is a significant
competitor of the Company as determined by the Board of Directors
of the Company in its reasonable discretion.

      3.3   Transferability.  This Warrant may be transferred  or
assigned in whole or in part, at any time, and from time to time,
to any Majority-Owned Subsidiary.  Subject to the restrictions on
transfer set forth in the Investor Rights Agreement, the  Warrant
may  also  be  transferred or assigned in whole or  in  any  part
representing not less than 100,000 Shares (subject to appropriate
adjustment  for  stock splits, stock dividends or  other  similar
events   where   all  holders  of  the  Company's  Common   Stock
participate on a pro rata basis), at any time, and from  time  to
time,  to  any  Institutional Investor.   The  Holder  agrees  to
provide  the  Company with five (5) business days  prior  written
notice  of  any  transfer or assignment of any  portion  of  this
Warrant  to  any  person or entity that is not a  Majority  Owned
Subsidiary  and  prompt  written notice  of  any  transfer  to  a
Majority Owned Subsidiary.

4.   MISCELLANEOUS.

      4.1   Legends.   Any  certificate for  Shares  issued  upon
exercise  hereof will be imprinted with a legend in substantially
the form set forth in the Common Stock Warrant Notice of Exercise
form attached hereto as Annex I.

     4.2  Investor Rights Agreement.  This Warrant and the Shares
are  subject to the terms and conditions of that certain Investor
Rights Agreement between the Company and Intel Corporation  dated
as of February 28, 1997 (the "Investor Rights Agreement").

      4.3   Successors and Assigns.  The terms and provisions  of
this  Warrant will inure to the benefit of, and be binding  upon,
the  Company  and the Holder and their respective successors  and
assigns of the Holder and of the Company.

      4.4   Governing Law.  This Warrant will be governed by  and
construed  under  the internal laws of the State  of  California,
without reference to principles of conflict of laws or choice  of
laws.

      4.5   Headings.   The headings and captions  used  in  this
Warrant  are  used  for  convenience  only  and  are  not  to  be
considered  in  construing  or interpreting  this  Warrant.   All
references  in this Warrant to sections and annexes will,  unless
otherwise  provided,  refer to sections and  hereof  and  annexes
attached hereto, all of which annexes are incorporated herein  by
this reference.

       4.6   Notices.   Unless  otherwise  provided,  any  notice
required  or  permitted  under this Warrant  shall  be  given  in
writing, shall be effective when received, and shall in any event
be  deemed received and effectively given upon personal  delivery
to  the  party  to be notified or three (3) business  days  after
deposit  with  the  United States Post Office, by  registered  or
certified  mail, postage prepaid, or one (1) business  day  after
deposit with a nationally recognized

<PAGE> 8

courier  service  such as Fedex, or one (1)  business  day  after
facsimile  with  copy delivered by registered or certified  mail,
postage prepaid and addressed to the party to be notified at  the
address indicated for such party on the signature page hereof  or
at  such  other  address  as  the Investor  or  the  Company  may
designate by giving at least ten (10) days advance written notice
pursuant to this Section 4.6.

                                 Xircom, Inc.
                                 
                                 By:  /s/Randall H. Holliday
                                 Name:  Randall H. Holliday
                                 Title:General Counsel and
Accepted                               Secretary
                                 
Intel Corporation                

By:  /s/Satish Rishi             
Name:  Satish Rishi              
Title:  Assistant Treasurer      
                                 
<PAGE> 9

                            ANNEX TO
                             WARRANT
                                
                     ______________, 199___
                                
Xircom, Inc.
2300 Corporate Center Drive
Thousand Oak, California 91320
Attention:  Chief Financial Officer

             Common Stock Warrant Notice of Exercise
             --------------------------------------

Gentlemen:

      On  this date the undersigned hereby acquires from  Xircom,
Inc.,  a California corporation (the "Company"), an aggregate  of
________  shares  of  the Company's Common  Stock  (the  "Warrant
Shares"), by exercise, for such number of shares, of that certain
Warrant to Purchase Shares of Common Stock (the "Warrant"), dated
as  of  February 28, 1997 from the Company to the original holder
of  the  Warrant.  However, if this exercise of  the  Warrant  is
subject  to the Hart-Scott-Rodino Antitrust Improvements  Act  of
1976  (the "HSR Act") filing requirements, this Warrant shall  be
deemed  to  have been exercised on the date immediately following
the  date of the expiration or early termination of all  HSR  Act
restrictions.

1.    Investment Representations and Warranties.  The undersigned
represents and warrants that:

      1.1   Purchase for Own Account.  The Warrant Shares  to  be
purchased by the undersigned will be acquired for investment  for
the undersigned's own account, not as a nominee or agent, and not
with  a  view to the public resale or distribution thereof within
the  meaning of the Securities Act of 1933, as amended (the "1933
Act"),  and the undersigned has no present intention of  selling,
granting  any  participation  in, or otherwise  distributing  the
same.   The  undersigned also represents that  it  has  not  been
formed for the specific purpose of acquiring the Warrant Shares.

       1.2   Disclosure  of  Information.   The  undersigned  has
received  or  has  had  full access to  all  the  information  it
considers necessary or appropriate to make an informed investment
decision  with respect to the Warrant Shares to be  purchased  by
the undersigned.

      1.3   Investment  Experience.  The undersigned  understands
that  the  purchase  of  the Warrant Shares involves  substantial
risk.   The  undersigned:  (a) has experience as an  investor  in
securities of companies and acknowledges that it is able to  fend
for  itself, can bear the economic risk of its investment in  the
Warrant Shares and has such knowledge and experience in financial
or  business matters that it is capable of evaluating the  merits
and risks of this investment in the Warrant Shares and protecting
its  own interests in connection with this investment and/or  (b)
has  a  preexisting  personal or business relationship  with  the
Company and certain of its

<PAGE> 10

officers,  directors  or  controlling persons  of  a  nature  and
duration  that  enables  the  undersigned  to  be  aware  of  the
character,  business acumen and financial circumstances  of  such
persons.

      1.4   Accredited  Investor  Status.   The  Investor  is  an
"accredited   investor"  within  the  meaning  of  Regulation   D
promulgated under the 1933 Act.

      1.5   Restricted  Securities.  The undersigned  understands
that  the  Warrant  Shares  to be purchased  by  the  undersigned
hereunder, are characterized as "restricted securities" under the
1933 Act inasmuch as they are being acquired from the Company  in
a  transaction not involving a public offering and that under the
1933  Act  and applicable regulations thereunder such  securities
may  be  resold without registration under the 1933 Act  only  in
certain limited circumstances.  The undersigned is familiar  with
Rule 144 of the SEC, as presently in effect, and understands  the
resale  limitations imposed thereby and by  the  1933  Act.   The
undersigned  understands that the Company is under no  obligation
to  register  any  of  the securities sold  hereunder  except  as
provided in the Investor Rights Agreement between the Company and
Intel  Corporation dated as of February 28, 1997  (the  "Investor
Rights Agreement").

     1.6  Further Limitations on Disposition.  Without in any way
limiting  the  representations set forth above,  the  undersigned
further  agrees not to make any disposition of all or any portion
of the Warrant Shares unless and until:

           (a)   there is then in effect a registration statement
under  the 1933 Act covering such proposed disposition  and  such
disposition   is  made  in  accordance  with  such   registration
statement; or

           (b)   the undersigned has notified the Company of  the
proposed  disposition  and  has  furnished  the  Company  with  a
statement   of   the  circumstances  surrounding   the   proposed
disposition,  and the undersigned has furnished the  Company,  at
the expense of the undersigned or its transferee, with an opinion
of  counsel,  reasonably satisfactory to the Company,  that  such
disposition  will  not require registration  of  such  securities
under the 1933 Act.

Notwithstanding the provisions of paragraphs (a) and (b) of  this
Section 1.6, no such registration statement or opinion of counsel
will  be  required  for  any transfer of any  Warrant  Shares  in
compliance  with SEC Rule 144, Rule 144A or Rule  145(d),  or  if
such  transfer otherwise is exempt, in the view of the  Company's
legal  counsel, from the registration requirements  of  the  1933
Act.

      1.7   Investor Rights Agreement.    The undersigned  agrees
and acknowledges that the Warrant Shares are subject to the terms
and conditions or the Investor Rights Agreement.

2.    Legends.   The  undersigned understands  that  certificates
evidencing  the Warrant Shares will bear each of the legends  set
forth below:

      2.1   THE  SECURITIES  REPRESENTED  HEREBY  HAVE  NOT  BEEN
REGISTERED  UNDER  THE SECURITIES ACT OF 1933,  AS  AMENDED  (THE
"ACT"),  OR  UNDER THE SECURITIES LAWS OF CERTAIN STATES.   THESE
SECURITIES  ARE  SUBJECT TO RESTRICTIONS ON  TRANSFERABILITY  AND
RESALE AND MAY NOT

<PAGE> 11

BE  TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE  ACT  AND
THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR
EXEMPTION THEREFROM.  INVESTORS SHOULD BE AWARE THAT THEY MAY  BE
REQUIRED  TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT  FOR  AN
INDEFINITE  PERIOD OF TIME.  THE ISSUER OF THESE  SECURITIES  MAY
REQUIRE  AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY
TO  THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE
IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES
LAWS.

     2.2  THE SHARES EVIDENCED BY THIS CERTIFICATE ARE SUBJECT TO
CERTAIN  RESTRICTIONS  SPECIFIED IN  A  CERTAIN  INVESTOR  RIGHTS
AGREEMENT BETWEEN THE COMPANY AND INTEL CORPORATION DATED  AS  OF
FEBRUARY  28, 1997, A COPY OF WHICH IS AVAILABLE FOR  EXAMINATION
AT THE ISSUER'S PRINCIPAL OFFICE.

     2.3  Any legends required by any applicable state securities
laws.

The  undersigned  agrees that, to ensure and  enforce  compliance
with  the  restrictions  imposed  by  applicable  law  and  those
referred  to  in the foregoing legend, or elsewhere  herein,  the
Company may issue appropriate "stop transfer" instructions to its
transfer agent, if any, with respect to any certificate or  other
instrument representing Warrant Shares.

3.    Net  Exercise  Election.   If applicable,  the  undersigned
elects to purchase the Warrant Shares by Net Exercise (as defined
in  the  Warrant), by initialing in the following  space  (please
initial only if Net Exercise chosen): _________

4.    Same  Day  Sale Election.  If applicable,  the  undersigned
elects to purchase the Warrant Shares by "same day sale" pursuant
to the provisions of Section 1.3(b) of the Warrant, by initialing
on  the  following space (please initial only if  Same  Day  Sale
chosen): _________

By:  ______________________________

Name:  ____________________________

Title:  ___________________________

Address:  _________________________

          _________________________

Date Signed:  _____________________

                 [SIGNATURE PAGE - XIRCOM, INC.
            COMMON STOCK WARRANT NOTICE OF EXERCISE]
                                


                            EXHIBIT 3
                                
                    INVESTOR RIGHTS AGREEMENT
                                
<PAGE>

                          XIRCOM, INC.
                                
                    INVESTOR RIGHTS AGREEMENT
                                
      This  Investor Rights Agreement (this "Agreement") is  made
and  entered  into as of February 28, 1997, by and among  Xircom,
Inc.,   a  California  corporation  (the  "Company"),  and  Intel
Corporation, a Delaware corporation (the "Investor").

                         R E C I T A L S
                         --------------
      A.    The Investor has agreed to purchase from the Company,
and the Company has agreed to sell to the Investor, shares of the
Company's  Common Stock (the "Common Stock") and a  Warrant  (the
"Warrant") on the terms and conditions set forth in that  certain
Common  Stock and Warrant Purchase Agreement, dated of even  date
herewith  by  and  between  the Company  and  the  Investor  (the
"Purchase Agreement").

     B.   The Purchase Agreement provides that the Investor shall
be  granted  certain information rights, registration rights  and
other rights, all as more fully set forth herein.

      NOW, THEREFORE, in consideration of the foregoing recitals,
the  mutual  promises hereinafter set forth, and other  good  and
valuable consideration, the receipt and sufficiency of which  are
hereby acknowledged, the parties hereto agree as follows:

1.   INFORMATION RIGHTS.

      1.1   Financial  Information.  The  Company  covenants  and
agrees  that,  commencing on the date of this Agreement,  for  so
long  as  the Investor holds shares of Common Stock issued  under
this  Agreement  or the Purchase Agreement or  shares  of  Common
Stock issued or issuable pursuant to exercise of the Warrant, the
Company will:

           (a)  Annual Reports.  Furnish to the Investor promptly
following the filing of such report with the U.S. Securities  and
Exchange  Commission (the "SEC"), a copy of the Company's  Annual
Report  on Form 10-K for each fiscal year, which shall include  a
consolidated Balance Sheet as of the end of such fiscal  year,  a
consolidated Statement of Income and a consolidated Statement  of
Cash  Flows  of the Company and its subsidiaries for  such  year,
setting  forth in each case in comparative form the figures  from
the  Company's  previous fiscal year, all prepared in  accordance
with  generally accepted accounting principles and practices  and
audited  by  nationally recognized independent  certified  public
accountants.   In  the  event  the Company  shall  no  longer  be
required to file Annual Reports on Form 10-K, the Company  shall,
within  ninety  (90)  days following the end of  each  respective
fiscal  year,  deliver  to the Investor a copy  of  such  Balance
Sheet, Statement of Income and Statement of Cash Flows.

           (b)   Quarterly  Reports.   Furnish  to  the  Investor
promptly following the filing of such report with the SEC, a copy
of  each  of the Company's Quarterly Reports on Form 10-Q,  which
shall  include a consolidated Balance Sheet as of the end of  the
respective fiscal quarter,

<PAGE> 2

consolidated Statements of Income and consolidated Statements  of
Cash Flows of the Company and its subsidiaries for the respective
fiscal  quarter and for the year-to-date, setting forth  in  each
case  in comparative form the figures from the comparable periods
in  the Company's immediately preceding fiscal year, all prepared
in  accordance with generally accepted accounting principles  and
practices, but all of which may be unaudited.  In the  event  the
Company shall no longer be required to file Quarterly Reports  on
Form  10-Q,  the  Company  shall,  within  forty-five  (45)  days
following the end of each of the first three (3) fiscal  quarters
of  each  fiscal  year, deliver to the Investor a  copy  of  such
Balance Sheet, Statements of Income and Statements of Cash Flows.

           (c)   SEC Filings.  The Company shall deliver  to  the
Investor  copies of each other document filed with  the  SEC  (as
defined  herein) promptly following the filing of  such  document
with the SEC.

     1.2  Board Observer.  So long as the Investor, together with
its  Majority Owned Subsidiaries (as defined in Section  6.1(c)),
holds at least the number of shares of the Company's Common Stock
equal  to  twelve and one-half percent (12.5%) of the  number  of
shares  of the Company's Common Stock and other voting securities
outstanding on the day immediately preceding the date of  closing
of  the  Purchase Agreement minus 100 shares (such number  to  be
proportionately adjusted for stock splits, stock  dividends,  and
similar events), the Company will permit a representative of  the
Investor,  reasonably acceptable to the Company (the  "Observer")
to  attend all meetings of the Company's Board of Directors  (the
"Board")  (whether  in person, telephonic or  other)  in  a  non-
voting,  observer  capacity and shall provide  to  the  Investor,
concurrently  with  the  members of the  Board,  notice  of  such
meeting  and  a  copy of all materials provided to such  members.
For  so  long  as the Investor shall be entitled  to  appoint  an
Observer pursuant to this section, the Investor shall, by written
election  delivered to the Company, be entitled  to  designate  a
representative  for appointment or election  to  the  Board  (the
"Representative"),  in lieu of the observer  contemplated  above.
Upon  written request of the Investor, the Company shall use  its
reasonable best efforts to cause the representative designated by
the  Investor  to be elected to the Board, including recommending
to  the  stockholders  of  the Company that  they  vote  for  the
election  to  the  Board  of  the individual  designated  by  the
Investor.    The  Company  shall  be  entitled  to   recuse   the
Representative or Observer, as the case may be, from portions  of
any  Board  meeting and to redact portions of Board of  Directors
materials  delivered to the Representative or Observer where  and
to  the  extent  that  the Board (without the  Representative  or
Observer present) determines a conflict of interest is present.

2.   REGISTRATION RIGHTS.

     2.1  Definitions.  For purposes of this Section 2:

          (a)  Registration.  The terms "register," "registered,"
and  "registration" refer to a registration effected by preparing
and  filing  a  registration statement  in  compliance  with  the
Securities  Act of 1933, as amended, (the "Securities Act"),  and
the declaration or ordering of effectiveness of such registration
statement

           (b)   Registrable  Securities.  The term  "Registrable
Securities"  means:  (l) all the shares of Common  Stock  of  the
Company issued or issuable (A) under the Purchase Agreement,

<PAGE> 3

(B)  pursuant  to  an exercise of the Warrant (shares  issued  or
issuable  upon exercise of the Warrant are referred to herein  as
the  "Warrant  Shares"),  and  (C)  pursuant  to  the  Right   of
Participation  (defined  in Section 3 hereof)  or  the  Right  of
Maintenance (defined in Section 4 hereof), and (2) any shares  of
Common  Stock  of  the Company issued as (or  issuable  upon  the
conversion  or  exercise of any warrant, right or other  security
which is issued as) a dividend or other distribution with respect
to,  or in exchange for or in replacement of, any such shares  of
Common  Stock  described in clause (1) of  this  subsection  (b).
Notwithstanding  the  foregoing, "Registrable  Securities"  shall
exclude  any  Registrable  Securities  sold  by  a  person  in  a
transaction in which rights under this Section 2 are not assigned
in  accordance with this Agreement or any Registrable  Securities
sold  in  a  public offering, whether sold pursuant to  Rule  144
promulgated  under  the  Securities  Act,  or  in  a   registered
offering, or otherwise.

           (c)   Registrable  Securities Then  Outstanding.   The
number  of  shares  of "Registrable Securities then  outstanding"
shall  mean  the  number  of  shares of  Common  Stock  that  are
Registrable Securities and (l) are then issued and outstanding or
(2) are then issuable pursuant to an exercise of the Warrant.

           (d)  Holder.  For purposes of this Section 2, the term
"Holder" means any person owning of record Registrable Securities
that  have  not been sold to the public or pursuant to  Rule  144
promulgated under the Securities Act or any permitted assignee of
record  of such Registrable Securities to whom rights under  this
Section  2  have  been  duly assigned  in  accordance  with  this
Agreement.

           (e)   Form  S-3.  The term "Form S-3" means such  form
under  the  Securities Act as is in effect on the date hereof  or
any   successor  registration  form  under  the  Securities   Act
subsequently  adopted  by  the SEC  which  permits  inclusion  or
incorporation  of substantial information by reference  to  other
documents filed by the Company with the SEC.

           (f)   SEC.   The term "SEC" or "Commission" means  the
U.S. Securities and Exchange Commission.

     2.2  Demand Registration.

           (a)  Request by Holders.  If the Company shall at  any
time  after  the first anniversary of the Closing, as defined  in
the  Purchase  Agreement,  receive a  written  request  from  the
Holders  of at least twenty-five percent (25%) of the Registrable
Securities  then outstanding that the Company file a registration
statement  under the Securities Act covering the registration  of
Registrable  Securities pursuant to this Section  2.2,  then  the
Company  shall, within ten (10) business days of the  receipt  of
such  written  request,  give  written  notice  of  such  request
("Request  Notice") to all Holders, and use its best  efforts  to
effect,  as  soon  as  practicable, the  registration  under  the
Securities Act of all Registrable Securities that Holders request
to  be  registered and included in such registration  by  written
notice given such Holders to the Company within twenty (20)  days
after  receipt  of  the  Request  Notice,  subject  only  to  the
limitations  of  this Section 2.2; provided that the  Registrable
Securities requested by all Holders to be registered pursuant  to
such  request  must  be  at least fifteen percent  (15%)  of  all
Registrable  Securities then outstanding;  and  provided  further
that  the  Company  shall not be obligated  to  effect  any  such
registration if the

<PAGE> 4

Company  has, within the six (6) month period preceding the  date
of  such  request,  already  effected a  registration  under  the
Securities Act pursuant to this Section 2.2 or Section 2.4, or in
which  the Holders had an opportunity to participate pursuant  to
the  provisions  of  Section 2.3, other than a registration  from
which  the  Registrable Securities of Holders have been  excluded
(with respect to all or any portion of the Registrable Securities
the  Holders requested be included in such registration) pursuant
to the provisions of Section 2.3(a).

           (b)   Underwriting.   If  the Holders  initiating  the
registration   request  under  this  Section   2.2   ("Initiating
Holders") intend to distribute the Registrable Securities covered
by  their request by means of an underwriting, then they shall so
advise  the  Company as a part of their request made pursuant  to
this  Section 2.2 and the Company shall include such  information
in  the written notice referred to in subsection 2.2(a).  In such
event,  the  right  of  any  Holder to  include  his  Registrable
Securities  in such registration shall be conditioned  upon  such
Holder's participation in such underwriting and the inclusion  of
such  Holder's Registrable Securities in the underwriting (unless
otherwise  mutually  agreed  by a majority  in  interest  of  the
initiating  Holders  and  such Holder)  to  the  extent  provided
herein.   All  Holders proposing to distribute  their  securities
through  such  underwriting  shall  enter  into  an  underwriting
agreement  in  customary  form with the managing  underwriter  or
underwriters selected for such underwriting by the Holders  of  a
majority  of  the  Registrable Securities  being  registered  and
reasonably  acceptable to the Company (including a market  stand-
off   agreement   of  up  to  180  days  if  required   by   such
underwriters).   Notwithstanding  any  other  provision  of  this
Section  2.2,  if  the underwriter(s) advise(s)  the  Company  in
writing that marketing factors require a limitation of the number
of securities to be underwritten then the Company shall so advise
all  Holders  of Registrable Securities which would otherwise  be
registered  and underwritten pursuant hereto, and the  number  of
Registrable  Securities that may be included in the  underwriting
shall  be reduced as required by the underwriter(s) and allocated
among  the Holders of Registrable Securities on a pro rata  basis
according   to   the  number  of  Registrable   Securities   then
outstanding   held   by   each  Holder  requesting   registration
(including the initiating Holders); provided, however,  that  the
number of shares of Registrable Securities to be included in such
underwriting  and  registration shall not be reduced  unless  all
other securities of the Company are first entirely excluded  from
the  underwriting  and registration.  Any Registrable  Securities
excluded  and withdrawn from such underwriting shall be withdrawn
from the registration.

           (c)   Maximum  Number  of Demand  Registrations.   The
Company  shall  be  obligated  to  effect  only  three  (3)  such
registrations pursuant to this Section 2.2.

           (d)  Deferral.  Notwithstanding the foregoing, if  the
Company  shall  furnish to Holders requesting  the  filing  of  a
registration   statement  pursuant  to  this   Section   2.2,   a
certificate signed by the President or Chief Executive Officer of
the Company stating that in the good faith judgment of the Board,
it  would  be  materially  detrimental to  the  Company  and  its
stockholders  for such registration statement to be  filed,  then
the  Company  shall  have the right to defer such  filing  for  a
period  of  not more than ninety (90) days after receipt  of  the
request  of the initiating Holders; provided, however,  that  the
Company  may not utilize this right more than once in any  twelve
(12) month period.

<PAGE> 5

           (e)   Expenses.  All expenses incurred  in  connection
with  any  registration pursuant to this Section  2.2,  including
without  limitation  all  federal and  "blue  sky"  registration,
filing and qualification fees, printer's and accounting fees, and
fees  and disbursements of counsel for the Company (but excluding
underwriters' discounts and commissions relating to  shares  sold
by  the Holders and legal fees of counsel for the Holders), shall
be  borne  by  the  Company.   Each  Holder  participating  in  a
registration  pursuant  to  this  Section  2.2  shall  bear  such
Holder's proportionate share (based on the total number of shares
sold  in  such  registration other than for the  account  of  the
Company)  of all discounts, commissions or other amounts  payable
to  underwriters  or  brokers, and the Holders'  legal  fees,  in
connection  with  such offering by the Holders.   Notwithstanding
the  foregoing, the Company shall not be required to pay for  any
expenses  of any registration proceeding begun pursuant  to  this
Section 2.2 if the registration request is subsequently withdrawn
at  the  request of the Holders of a majority of the  Registrable
Securities to be registered, unless the Holders of a majority  of
the  Registrable  Securities  then outstanding  agree  that  such
registration constitutes the use by the Holders of one (1) demand
registration  pursuant to this Section 2.2 (in  which  case  such
registration  shall also constitute the use  by  all  Holders  of
Registrable  Securities  of  one (l) such  demand  registration);
provided,  further,  however,  that  if  at  the  time  of   such
withdrawal, the Holders have learned of a material adverse change
in the condition, business, or prospects of the Company not known
to the Holders at the time of their request for such registration
and have withdrawn their request for registration with reasonable
promptness  after learning of such material adverse change,  then
the Holders shall not be required to pay any of such expenses and
such  registration  shall not constitute  the  use  of  a  demand
registration pursuant to this Section 2.2.

      2.3  Piggyback Registrations.  The Company shall notify all
Holders of Registrable Securities in writing at least thirty (30)
days  prior  to  filing  any  registration  statement  under  the
Securities  Act  for purposes of effecting a public  offering  of
securities  of  the  Company  (including,  but  not  limited  to,
registration  statements  relating  to  secondary  offerings   of
securities  of the Company, but excluding registration statements
relating to any registration under Section 2.2 or Section 2.4  of
this Agreement, to any employee benefit plan or to any merger  or
other  corporate reorganization) and will afford each such Holder
an  opportunity to include in such registration statement all  or
any  part of the Registrable Securities then held by such Holder.
Each   Holder  desiring  to  include  in  any  such  registration
statement all or any part of the Registrable Securities  held  by
such  Holder shall within twenty (20) days after receipt  of  the
above-described notice from the Company, so notify the Company in
writing,  and  in  such notice shall inform the  Company  of  the
number of Registrable Securities such Holder wishes to include in
such  registration statement.  If a Holder decides not to include
all  of  its Registrable Securities in any registration statement
thereafter  filed by the Company, such Holder shall  nevertheless
continue  to have the right to include any Registrable Securities
in   any   subsequent  registration  statement  or   registration
statements  as  may  be  filed by the  Company  with  respect  to
offerings  of  its securities, all upon the terms and  conditions
set forth herein.

           (a)   Underwriting.  If a registration statement under
which  the Company gives notice under this Section 2.3 is for  an
underwritten  offering,  then the Company  shall  so  advise  the
Holders  of Registrable Securities.  In such event, the right  of
any  such  Holder's Registrable Securities to be  included  in  a
registration  pursuant to this Section 2.3 shall  be  conditioned
upon  such  Holder's participation in such underwriting  and  the
inclusion of such Holder's Registrable

<PAGE> 6

Securities  in  the underwriting to the extent  provided  herein.
All  Holders proposing to distribute their Registrable Securities
through  such  underwriting  shall  enter  into  an  underwriting
agreement  in  customary  form with the managing  underwriter  or
underwriters selected for such underwriting (including  a  market
stand-off  agreement  of  up to 180  days  if  required  by  such
underwriters).   Notwithstanding  any  other  provision  of  this
Agreement, if the managing underwriter determine(s) in good faith
that  marketing  factors require a limitation of  the  number  of
shares  to be underwritten, then the managing underwriter(s)  may
exclude  shares  from the registration and the underwriting,  and
the number of shares that may be included in the registration and
the  underwriting shall be allocated, first to the  Company,  and
second,  to each of the Holders and other holders of registration
rights on a parity with the Holders requesting inclusion of their
Registrable Securities in such registration statement  on  a  pro
rata  basis  based on the total number of Registrable  Securities
and  other securities entitled to registration then held by  each
such Holder or other holder; provided, however, that the right of
the   underwriters  to  exclude  shares  (including   Registrable
Securities)  from the registration and underwriting as  described
above  shall  be restricted so that (i) the number of Registrable
Securities included in any such registration is not reduced below
twenty-five  percent (25%) of the aggregate number of Registrable
Securities for which inclusion has been requested; and  (ii)  all
shares  that are not Registrable Securities and are held  by  any
other person, including, without limitation, any person who is an
employee,  officer or director of the Company (or any  subsidiary
of  the  Company) shall first be excluded from such  registration
and  underwriting  before  any  Registrable  Securities  are   so
excluded  (other  than to the extent that such persons  are  non-
employee directors or other non-employees of the Company who hold
registration  rights  on  a parity with the  Holders,  such  non-
employee  directors  and other non-employees  being  entitled  to
participate with the participating Holders on the basis described
under "second" above).  If any Holder disapproves of the terms of
any   such  underwriting,  such  Holder  may  elect  to  withdraw
therefrom  by  written notice to the Company and the underwriter,
delivered  at least ten (10) business days prior to the effective
date  of  the registration statement.  Any Registrable Securities
excluded  or  withdrawn from such underwriting shall be  excluded
and  withdrawn from the registration.  For any Holder that  is  a
partnership, the Holder and the partners and retired partners  of
such  Holder,  or  the  estates and family members  of  any  such
partners  and retired partners and any trusts for the benefit  of
any  of  the  foregoing persons, and for any  Holder  that  is  a
corporation, the Holder and all corporations that are  affiliates
of  such Holder, shall be deemed to be a single "Holder," and any
pro  rata reduction with respect to such "Holder" shall be  based
upon  the aggregate amount of shares carrying registration rights
owned  by all entities and individuals included in such "Holder,"
as defined in this sentence.

           (b)   Expenses.  All expenses incurred  in  connection
with  a  registration  pursuant to this  Section  2.3  (excluding
underwriters' and brokers' discounts and commissions relating  to
shares  sold  by  the Holders and legal fees of counsel  for  the
Holders),  including, without limitation all  federal  and  "blue
sky"  registration, filing and qualification fees, printers'  and
accounting  fees, and fees and disbursements of counsel  for  the
Company, shall be borne by the Company.

          (c)  Not Demand Registration.  Registration pursuant to
this  Section 2.3 shall not be deemed to be a demand registration
as  described in Section 2.2 above.  Except as otherwise provided
herein,  there  shall  be no limit on the  number  of  times  the
Holders may request registration of Registrable Securities  under
this Section 2.3.

<PAGE> 7

      2.4   Form S-3 Registration.  In case the Company shall  at
any  time after the first anniversary of the Closing, as  defined
in  the Purchase Agreement, receive from any Holder or Holders of
a  majority  of  all  Registrable Securities then  outstanding  a
written   request   or  requests  that  the  Company   effect   a
registration  on  Form  S-3  and  any  related  qualification  or
compliance  with  respect  to all or a part  of  the  Registrable
Securities  owned  by such Holder or Holders,  then  the  Company
will:

           (a)   Notice.   Promptly give written  notice  of  the
proposed  registration  and  the  Holder's  or  Holders'  request
therefor,  and  any related qualification or compliance,  to  all
other Holders of Registrable Securities; and

          (b)  Registration.  As soon as practicable, effect such
registration and all such qualifications and compliances  as  may
be  so  requested and as would permit or facilitate the sale  and
distribution of all or such portion of such Holders  or  Holders'
Registrable Securities as are specified in such request, together
with  all  or such portion of the Registrable Securities  of  any
other  Holder or Holders joining in such request as are specified
in  a  written  request given within twenty (20) days  after  the
Company  provides  the  notice contemplated  by  Section  2.4(a);
provided,  however, that the Company shall not  be  obligated  to
effect   any   such  registration,  qualification  or  compliance
pursuant to this Section 2.4:

                (1)   if  Form  S-3  is not  available  for  such
offering by the Holders:

                (2)  if the Holders, together with the holders of
any other securities of the Company entitled to inclusion in such
registration,  propose to sell Registrable  Securities  and  such
other securities (if any) at an aggregate price to the public  of
less than $5,000,000;

               (3)  if the Company shall furnish to the Holders a
certificate signed by the President or Chief Executive Officer of
the  Company stating that in the good faith judgment of the Board
of  Directors of the Company, it would be materially  detrimental
to   the   Company  and  its  shareholders  for  such  Form   S-3
Registration  to  be effected at such time, in  which  event  the
Company shall have the right to defer the filing of the Form  S-3
registration statement no more than once during any twelve  month
period  for  a  period of not more than ninety  (90)  days  after
receipt  of  the  request of the Holder  or  Holders  under  this
Section 2.4;

                (4)  if the Company has, within the six (6) month
period  preceding  the date of such request, already  effected  a
registration  under the Securities Act other than a  registration
from  which  the  Registrable Securities  of  Holders  have  been
excluded  (with respect to all or any portion of the  Registrable
Securities   the   Holders  requested   be   included   in   such
registration) pursuant to the provisions of Section 2.3(a); or

                (5)  in any particular jurisdiction in which  the
Company would be required to qualify to do business or to execute
a  general  consent  to  service of  process  in  effecting  such
registration, qualification or compliance.

           (c)   Expenses.   The Company shall pay  all  expenses
incurred  in connection with each registration requested pursuant
to this Section 2.4, (excluding underwriters' or brokers'

<PAGE> 8

discounts and commissions relating to shares sold by the  Holders
and  legal  fees  of counsel for the Holders), including  without
limitation  federal  and  "blue  sky"  registration,  filing  and
qualification fees, printers' and accounting fees, and  fees  and
disbursements of counsel.

           (d)  Deferral.  Notwithstanding the foregoing, if  the
Company  shall  furnish to Holders requesting  the  filing  of  a
registration   statement  pursuant  to  this   Section   2.4,   a
certificate signed by the President or Chief Executive Officer of
the Company stating that in the good faith judgment of the Board,
it  would  be  materially  detrimental to  the  Company  and  its
stockholders  for such registration statement to be  filed,  then
the  Company  shall  have the right to defer such  filing  for  a
period  of  not more than ninety (90) days after receipt  of  the
request  of the initiating Holders; provided, however,  that  the
Company  may not utilize this right more than once in any  twelve
(12) month period.

           (e)   Not Demand Registration.  Form S-3 registrations
shall  not  be deemed to be demand registrations as described  in
Section  2.2 above.  Except as otherwise provided herein, Holders
may  request  up  to  3  separate  registrations  of  Registrable
Securities under this Section 2.4.

      2.5   Obligations  of  the Company.  Whenever  required  to
effect the registration of any Registrable Securities under  this
Agreement  the  Company  shall, as  expeditiously  as  reasonably
possible:

          (a)  Registration Statement.  Prepare and file with the
SEC  a  registration statement with respect to  such  Registrable
Securities  and  use its best efforts to cause such  registration
statement  to  become  effective,  provided,  however,  that  the
Company  shall  not  be  required to keep any  such  registration
statement effective for more than ninety (90) days.

          (b)  Amendments and Supplements.  Prepare and file with
the  SEC  such  amendments and supplements to  such  registration
statement  and  the  prospectus  used  in  connection  with  such
registration  statement as may be necessary to  comply  with  the
provisions  of the Securities Act with respect to the disposition
of all securities covered by such registration statement.

           (c)  Prospectuses.  Furnish to the Holders such number
of copies of a prospectus, including a preliminary prospectus, in
conformity with the requirements of the Securities Act, and  such
other  documents  as  they may reasonably  request  in  order  to
facilitate the disposition of the Registrable Securities owned by
them that are included in such registration.

           (d)   Blue Sky.  Use its best efforts to register  and
qualify  the  securities  covered by such registration  statement
under   such   other  securities  or  Blue  Sky  laws   of   such
jurisdictions  as shall be reasonably requested by  the  Holders,
provided  that  the Company shall not be required  in  connection
therewith or as a condition thereto to qualify to do business  or
to  file  a  general consent to service of process  in  any  such
states or jurisdictions.

           (e)   Underwriting.  In the event of any  underwritten
public offering, enter into and perform its obligations under  an
underwriting agreement in usual and customary form, with

<PAGE> 9

the  managing  underwriter(s)  of  such  offering.   Each  Holder
participating  in  such underwriting shall also  enter  into  and
perform its obligations under such an agreement.

           (f)   Notification.  Notify each Holder of Registrable
Securities  covered by such registration statement  at  any  time
when  a  prospectus relating thereto is required to be  delivered
under  the  Securities Act of the happening of  any  event  as  a
result  of  which  the prospectus included in  such  registration
statement, as then in effect, includes an untrue statement  of  a
material  fact or omits to state a material fact required  to  be
stated  therein or necessary to make the statements  therein  not
misleading in the light of the circumstances then existing.

           (g)   Opinion  and Comfort Letter.   Furnish,  at  the
request  of  any  Holder requesting registration  of  Registrable
Securities,  on  the  date that such Registrable  Securities  are
delivered  to  the underwriters for sale, if such securities  are
being  sold through underwriters, or, if such securities are  not
being   sold   through  underwriters,  on  the  date   that   the
registration  statement with respect to such  securities  becomes
effective, (i) an opinion, dated as of such date, of the  counsel
representing  the Company for the purposes of such  registration,
in  form and substance as is customarily given to underwriters in
an underwritten public offering and reasonably satisfactory to  a
majority  in  interest  of  the Holders requesting  registration,
addressed  to  the  underwriters, if  any,  and  to  the  Holders
requesting  registration of Registrable  Securities  and  (ii)  a
"comfort"  letter  dated as of such date,  from  the  independent
certified  public  accountants  of  the  Company,  in  form   and
substance as is customarily given by independent certified public
accountants  to  underwriters in an underwritten public  offering
and  reasonably  satisfactory to a majority in  interest  of  the
Holders  requesting registration, addressed to the  underwriters,
if any, and to the Holders requesting registration of Registrable
Securities.

     2.6  Furnish Information.  It shall be a condition precedent
to  the obligations of the Company to take any action pursuant to
Sections  2.2, 2.3 or 2.4 that the selling Holders shall  furnish
to   the  Company  such  information  regarding  themselves,  the
Registrable Securities held by them, and the intended  method  of
disposition  of  such securities as shall be required  to  timely
effect the Registration of their Registrable Securities.

       2.7    Indemnification.   In  the  event  any  Registrable
Securities  are  included  in  a  registration  statement   under
Sections 2.2, 2.3 or 2.4:

           (a)   By the Company.  To the extent permitted by law;
the  Company  will indemnify and hold harmless each  Holder,  the
partners,  officers and directors of each Holder, any underwriter
(as  determined in the Securities Act) for such Holder  and  each
person,  if  any, who controls such Holder or underwriter  within
the  meaning of the Securities Act or the Securities Exchange Act
of  1934,  as  amended,  (the "1934 Act"),  against  any  losses,
claims, damages, or Liabilities (joint or several) to which  they
may  become  subject under the Securities Act, the  1934  Act  or
other  federal  or  state law, insofar as  such  losses,  claims,
damages, or liabilities (or actions in respect thereof) arise out
of  or  are based upon any of the following statements, omissions
or violations (collectively a "Violation"):

<PAGE> 10

                (i)   any  untrue  statement  or  alleged  untrue
          statement  of  a  material  fact  contained   in   such
          registration   statement,  including  any   preliminary
          prospectus or final prospectus contained therein or any
          amendments or supplements thereto;
          
                (ii)  the omission or alleged omission  to  state
          therein  a material fact required to be stated therein,
          or   necessary  to  make  the  statements  therein  not
          misleading, or
          
                (iii)      any violation or alleged violation  by
          the  Company of the Securities Act, the 1934  Act,  any
          federal  or  state  securities  law  or  any  rule   or
          regulation  promulgated under the Securities  Act,  the
          1934  Act  or  any federal or state securities  law  in
          connection   with   the  offering   covered   by   such
          registration statement;
          
and the Company will reimburse each such Holder, partner, officer
or  director, underwriter or controlling person for any legal  or
other  expenses  reasonably incurred by  them,  as  incurred,  in
connection with investigating or defending any such loss,  claim,
damage,   liability  or  action;  provided,  however,  that   the
indemnity agreement contained in this subsection 2.7(a) shall not
apply  to  amounts  paid in settlement of any such  loss,  claim,
damage,  liability  or  action  if such  settlement  is  effected
without  the consent of the Company (which consent shall  not  be
unreasonably  withheld), nor shall the Company be liable  in  any
such  case for any such loss, claim, damage, liability or  action
to  the extent that it arises out of or is based upon a Violation
which  occurs  in  reliance upon and in conformity  with  written
information furnished expressly for use in connection  with  such
registration   by   such  Holder,  partner,  officer,   director,
underwriter or controlling person of such Holder.

           (b)   By Selling Holders.  To the extent permitted  by
law,  each  selling Holder will indemnify and hold  harmless  the
Company,  each  of its directors, each of its officers  who  have
signed  the  registration statement, each  person,  if  any,  who
controls  the  Company within the meaning of the Securities  Act,
any  underwriter  and any other Holder selling  securities  under
such  registration  statement  or  any  of  such  other  Holder's
partners,  directors or officers or any person who controls  such
Holder within the meaning of the Securities Act or the 1934  Act,
against  any  losses,  claims, damages or liabilities  (joint  or
several)  to  which  the Company or any such  director,  officer,
controlling person, underwriter or other such Holder, partner  or
director, officer or controlling person of such other Holder  may
become  subject under the Securities Act, the 1934 Act  or  other
federal or state law, insofar as such losses, claims, damages  or
liabilities (or actions in respect thereto) arise out of  or  are
based upon any Violation, in each case to the extent (and only to
the  extent) that such Violation occurs in reliance upon  and  in
conformity  with  written information furnished  by  such  Holder
expressly for use in connection with such registration; and  each
such Holder will reimburse any legal or other expenses reasonably
incurred   by   the  Company  or  any  such  director,   officer,
controlling   person,  underwriter  or  other  Holder,   partner,
officer,  director or controlling person of such other Holder  in
connection with investigating or defending any such loss,  claim,
damage,   liability  or  action:  provided,  however,  that   the
indemnity agreement contained in this subsection 2.7(b) shall not
apply  to  amounts  paid in settlement of any such  loss,  claim,
damage,  liability  or  action  if such  settlement  is  effected
without  the  consent of the Holder, which consent shall  not  be
unreasonably  withheld;  and provided, further,  that  the  total
amounts

<PAGE> 11

payable  in  indemnity by a Holder under this Section  2.7(b)  in
respect  of  any  Violation shall not  exceed  the  net  proceeds
received  by such Holder in the registered offering out of  which
such Violation arises.

           (c)  Notice.  Promptly after receipt by an indemnified
party under this Section 2.7 of notice of the commencement of any
action  (including  any  governmental action),  such  indemnified
party  will, if a claim in respect thereof is to be made  against
any  indemnifying party under this Section 2.7,  deliver  to  the
indemnifying  party a written notice of the commencement  thereof
and  the  indemnifying party shall have the right to  participate
in, and, to the extent the indemnifying party so desires, jointly
with  any  other indemnifying party similarly noticed, to  assume
the  defense  thereof with counsel mutually satisfactory  to  the
parties; provided, however, that an indemnified party shall  have
the  right to retain its own counsel, with the fees and  expenses
to  be  paid  by  the  indemnifying party,  to  the  extent  that
representation of such indemnified party by the counsel  retained
by the indemnifying party would be inappropriate due to actual or
potential  conflict of interests between such  indemnified  party
and   any  other  party  represented  by  such  counsel  in  such
proceeding.   The  failure  to  deliver  written  notice  to  the
indemnifying  party within a reasonable time of the  commencement
of  any  such  action  shall relieve such indemnifying  party  of
liability to the indemnified party under this Section 2.7 to  the
extent  the indemnifying party is prejudiced as a result thereof,
but  the omission so to deliver written notice to the indemnified
party  will not relieve it of any liability that it may  have  to
any indemnified party otherwise than under this Section 2.7.

           (d)   Defect  Eliminated  in  Final  Prospectus.   The
foregoing  indemnity agreements of the Company  and  Holders  are
subject  to  the condition that, insofar as they  relate  to  any
Violation  made  in  a preliminary prospectus but  eliminated  or
remedied  in the amended prospectus on file with the SEC  at  the
time the registration statement in question becomes effective  or
the  amended prospectus filed with the SEC pursuant to  SEC  Rule
424(b)  (the "Final Prospectus"), such indemnity agreement  shall
not  inure  to the benefit of any person if a copy of  the  Final
Prospectus was timely furnished to the indemnified party and  was
not  furnished to the person asserting the loss, liability, claim
or  damage at or prior to the time such action is required by the
Securities Act.

           (e)   Contribution.  In order to provide for just  and
equitable  contribution to joint liability under  the  Securities
Act  in any case in which either (i) any Holder exercising rights
under  this  Agreement, or any controlling  person  of  any  such
Holder,  makes  a  claim  for indemnification  pursuant  to  this
Section  2.7 but it is judicially determined (by the entry  of  a
final judgment or decree by a court of competent jurisdiction and
the  expiration of time to appeal or the denial of the last right
of  appeal) that such indemnification may not be enforced in such
case notwithstanding the fact that this Section 2.7 provides  for
indemnification  in  such case, or (ii)  contribution  under  the
Securities  Act may be required on the part of any  such  selling
Holder or any such controlling person in circumstances for  which
indemnification is provided under this Section 2.7; then, and  in
each  such  case, the Company and such Holder will contribute  to
the  aggregate  losses, claims, damages or liabilities  to  which
they  may  be  subject (after contribution from others)  in  such
proportion  so  that such Holder is responsible for  the  portion
represented by the percentage that the public offering  price  of
its   Registrable  Securities  offered  by  and  sold  under  the
registration statement bears to the public offering price of  all
securities offered by and sold

<PAGE> 12

under  such  registration statement, and the  Company  and  other
selling  Holders  are  responsible  for  the  remaining  portion;
provided,  however, that, in any such case: (A)  no  such  Holder
will be required to contribute any amount in excess of the public
offering  price  of all such Registrable Securities  offered  and
sold by such Holder pursuant to such registration statement;  and
(B)  no  person  or entity guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act)  will
be entitled to contribution from any person or entity who was not
guilty of such fraudulent misrepresentation.

           (f)   Survival.   The obligations of the  Company  and
Holders  under  this Section 2.7 shall survive  until  the  fifth
anniversary  of  the  completion of any offering  of  Registrable
Securities  in  a  registration  statement,  regardless  of   the
expiration  of any statutes of limitation or extensions  of  such
statutes.

      2.8  Termination of the Company's Obligations.  The Company
shall have no obligations pursuant to this Section 2 with respect
to  any Registrable Securities proposed to be sold by a Holder in
a  registration  pursuant to Section 2.2, 2.3 or  2.4  more  than
seven (7) years after the date of this Agreement, or, if, in  the
opinion   of   counsel  to  the  Company,  all  such  Registrable
Securities proposed to be sold by a Holder may then be sold under
Rule   144  in  one  transaction  without  exceeding  the  volume
limitations thereunder.

      2.9  No Registration Rights to Third Parties.  Without  the
prior written consent of the Holders of a majority in interest of
the   Registrable  Securities  then  outstanding,   the   Company
covenants and agrees that it shall not grant, or cause or  permit
to  be  created,  for  the benefit of any person  or  entity  any
registration rights of any kind (whether similar to  the  demand,
"piggyback"  or  Form S-3 registration rights described  in  this
Article  2,  or  otherwise) relating to shares of  the  Company's
Common Stock or any other voting securities of the Company, other
than rights that are on a parity with or subordinate in right  to
the Holders.

3.   RIGHT OF PARTICIPATION.

       3.1    General.   The  Investor  and  any  Majority  Owned
Subsidiary of the Investor to which rights under this  Section  3
have  been  duly  assigned  in accordance  with  Section  6  (the
Investor and each such assignee being hereinafter referred to  as
a  "Participation Rights Holder") shall have the right  of  first
refusal  to purchase such Participation Rights Holder's Pro  Rata
Share  (as  defined  below), of all (or  any  part)  of  any  New
Securities (as defined in Section 3.3) that the Company may  from
time  to time issue after the date of this Agreement (the  "Right
of  Participation");  provided, however,  that  no  Participation
Rights  Holder shall have the Right of Participation with respect
to  any issuance of New Securities that would result in less than
a  ten  percent  (10%)  reduction in  such  Participation  Rights
Holder's Pro Rata Share.

      3.2   Pro Rata Share.  A Participation Rights Holder's "Pro
Rata  Share"  for purposes of the Right of Participation  is  the
ratio  of (a) the number of Registrable Securities held  by  such
Participation  Rights Holder, to (b) the difference  between  (i)
the  total  number of shares of Common Stock of the Company  (and
other  voting securities of the Company, if any) then outstanding
(immediately prior to the issuance of New Securities giving  rise
to  the  Right  of  Participation), where for such  purposes  all
Warrant Shares held by the Investor and its Majority

<PAGE> 13

Owned Subsidiaries are deemed outstanding, and (ii) the number of
Dilutive Securities (defined below) issued since the last  Notice
Date   (defined  below)  excluding  any  Maintenance   Securities
(defined below) issued pursuant to the last Maintenance Notice.

     3.3  New Securities.  "New Securities" shall mean any Common
Stock,  Preferred  Stock or other voting  capital  stock  of  the
Company,  whether now authorized or not, and rights,  options  or
warrants  to purchase such Common Stock or Preferred  Stock,  and
securities  of  any  type whatsoever that  are,  or  may  become,
convertible  or  exchangeable into such Common  Stock,  Preferred
Stock  or  other capital stock, provided, however, that the  term
"New Securities" shall not include:

           (a)   any shares of the Company's Common Stock (and/or
options  or  warrants  therefor) issued  to  employees  officers,
directors,  contractors, advisors or consultants of  the  Company
pursuant  to incentive agreements or incentive plans approved  by
the Board;

           (b)   any  shares  of Common Stock  issued  under  the
Purchase Agreement, as such agreement may be amended;

           (c)   the Warrant or any shares of Common Stock issued
upon any exercise thereof;

          (d)  any securities issued in connection with any stock
split  stock,  dividend  or  other similar  event  in  which  all
Participation Rights Holders are entitled to participate on a pro
rata basis;

            (e)    any   securities  issued  upon  the  exercise,
conversion  or  exchange  of  any outstanding  security  if  such
outstanding security constituted a New Security; or

           (f)  any securities issued pursuant to the acquisition
of another corporation or entity by the Company by consolidation,
merger, purchase of assets, or other reorganization in which  the
Company  acquires, in a single transaction or series  of  related
transactions, assets of such other corporation or entity or fifty
percent  (50%)  or  more  of  the  voting  power  of  such  other
corporation  or  entity or fifty percent (50%)  or  more  of  the
equity ownership of such other entity.

      3.4  Procedures.  In the event that the Company proposes to
undertake  an issuance of New Securities (in a single transaction
or  a series of related transactions) that would result in a  ten
percent (10%) or greater reduction in the Pro Rata Share of  each
Participation  Rights Holder, it shall give to each Participation
Rights  Holder  written  notice of its  intention  to  issue  New
Securities  (the "Participation Notice"), describing  the  amount
and  the  type  of New Securities and the price and  the  general
terms  upon  which  the  Company  proposes  to  issue  such   New
Securities. Each Participation Rights Holder shall have ten  (10)
business  days from the date of receipt of any such Participation
Notice  to agree in writing to purchase such Participation Rights
Holder's Pro Rata Share of such New Securities for the price  and
upon  the  terms  and conditions specified in  the  Participation
Notice  by  giving  written notice to  the  Company  and  stating
therein  the quantity of New Securities to be purchased  (not  to
exceed such Participation Rights Holder's Pro Rata

<PAGE> 14

Share).  If any Participation Rights Holder fails to so agree  in
writing within such ten (10) business day period to purchase such
Participation Rights Holder's full Pro Rata Share of an  offering
of  New  Securities, then such Participation Rights Holder  shall
forfeit the right hereunder to purchase that part of its Pro Rata
Share  of  such  New  Securities that it  did  not  so  agree  to
purchase.   Such Participation Rights Holder shall  purchase  the
portion  elected by such Participation Rights Holder concurrently
with  the  closing  of the transaction triggering  the  Right  of
Participation.

      3.5  Failure to Exercise.  Upon the expiration of such  ten
(10)  day  period, the Company shall have 120 days thereafter  to
sell  the  New  Securities described in the Participation  Notice
(with  respect to which the Participation Rights Holders'  rights
of  first refusal hereunder were not exercised), or enter into an
agreement to do so, within sixty (60) days thereafter, at no less
than  ninety-five percent (95%) of the price and  upon  non-price
terms  not  materially more favorable to the  purchasers  thereof
than  specified in the Participation Notice.  In the  event  that
the  Company  has not issued and sold such New Securities  within
such 120 day period, or entered into an agreement to do so within
sixty (60) days thereafter, then the Company shall not thereafter
issue  or  sell  any New Securities without again first  offering
such  New Securities to the Participation Rights Holders pursuant
to this Section 3.

      3.6   Termination.   The  Right of  Participation  for  the
Investor  and  each  other  Participation  Rights  Holder   shall
terminate  upon  the  first  date  that  the  Investor  and   its
Affiliates  (as  defined in Rule 144 under  the  Securities  Act)
collectively hold less than the number of shares of the Company's
Common Stock equal to twelve and one-half percent (12.5%) of  the
number  of shares of the Company's Common Stock and other  voting
securities outstanding on the day immediately preceding the  date
of  closing  of  the Purchase Agreement minus  100  shares  (such
number  to  be  proportionately adjusted for stock splits,  stock
dividends and similar events).

4.   RIGHT OF MAINTENANCE.

      4.1   General.   Each  Participation  Rights  Holder  will,
pursuant to the terms and conditions of this Section 4, have  the
right  to purchase shares of Common Stock, voting Preferred Stock
or other voting capital stock ("Maintenance Securities") from the
Company  at  the  Purchase  Price (as  defined  in  Section  4.3)
following the issuance by the Company of Dilutive Securities  (as
defined  in Section 4.2) that the Company may from time  to  time
issue  after  the  date of this Agreement,  solely  in  order  to
maintain  such  Participation Rights  Holder's  Prior  Percentage
Interest  (as defined in Section 4.4) in the Company (the  "Right
of  Maintenance").  Each right to purchase Maintenance Securities
pursuant to this Section 4 shall be on the same terms (other than
price  to  the  extent  provided in Section  4.3  below)  as  the
issuance  of the Dilutive Securities that gave rise to the  right
to purchase such Maintenance Securities

      4.2  Dilutive Securities.  "Dilutive Securities" means  any
Common  Stock,  voting  Preferred Stock or other  voting  capital
stock  of  the Company, whether now authorized or not;  provided,
however, that the term "Dilutive Securities" does not include:

<PAGE> 15

           (a)   any  securities other than Common Stock,  voting
Preferred Stock or other voting capital stock (e.g.,  warrants or
options  to  purchase  Common Stock,  Preferred  Stock  or  other
capital stock);

           (b)   any  shares  of Common Stock  issued  under  the
Purchase Agreement, as such agreement may be amended;

          (c)  the Warrant or any shares of Common Stock issuable
upon any exercise thereof;

          (d)  any securities issued in connection with any stock
split, stock dividend or similar event in which all Participation
Rights Holders are entitled to participate on a pro rata basis;

          (e)  any securities for which the issuance gave rise to
the  Right of Participation (regardless of whether any such right
was exercised); or

            (f)   any  securities  issuable  upon  the  exercise,
conversion or exchange of any securities described in (d) or  (e)
above.

     4.3  Purchase Price.

           (a)  Employee Stock.  To the extent that the right  to
purchase  Maintenance Securities arises out of  the  issuance  of
Dilutive    Securities   to   employees,   officers,   directors,
contractors, advisors or consultants of the Company  pursuant  to
incentive  agreements or incentive plans approved  by  the  Board
("Employee  Stock"),  the  per  share  "Purchase  Price"  of  the
Maintenance Securities shall equal the average Market  Price  (as
defined  below)  of such Maintenance Securities over  the  thirty
(30)  trading  days immediately preceding the date on  which  the
Participation  Rights Holder elects to purchase such  Maintenance
Securities.

          (b)  Other Dilutive Securities.  To the extent that the
right  to  purchase  Maintenance Securities  arises  out  of  any
issuance  of Dilutive Securities other than Employee  Stock,  the
per  share  "Purchase Price" of the Maintenance Securities  shall
equal  the  higher of (i) the weighted average of the  per  share
prices  at which such Dilutive Securities were issued,  and  (ii)
seventy-five  percent  (75%)  of the  average  Market  Price  (as
defined  below)  of such Maintenance Securities over  the  thirty
(30)  trading  days immediately preceding the date on  which  the
Participation  Rights Holder elects to purchase such  Maintenance
Securities.  For purposes hereof, in the event that the  issuance
of  any  Dilutive Securities occurs upon the exercise, conversion
or exchange of other securities ("Exchangeable Securities"), then
the  per  share price at which such Dilutive Securities shall  be
deemed to have been issued shall be the sum of (A) the per  share
amount paid upon such exercise, conversion or exchange, plus  (B)
the  per  share  amount  previously  paid  for  the  Exchangeable
Securities  (adjusted for any stock splits,  stock  dividends  or
other similar events).

           (c)   Market Price. For purposes of this Section  4.3,
"Market Price" means, as to any Maintenance Securities on a given
day,  the average of the closing prices of such security's  sales
on  all domestic securities exchanges on which such security  may
at the time be listed, or, if

<PAGE> 16

there  have been no sales on any such exchange on such  day,  the
average  of the highest bid and lowest asked prices on  all  such
exchanges at the end of such day, or, if on any day such security
is not so listed, the average of the representative bid and asked
prices quoted in the NASDAQ National Market as of 4:00 P.M.,  New
York  time, on such day, or, if on any day such security  is  not
quoted  in the NASDAQ National Market, the average of the highest
bid and lowest asked prices on such day in the domestic over-the-
counter  market  as  reported by the National  Quotation  Bureau,
Incorporated, or any similar successor organization.  If  at  any
time  the  Maintenance Securities are not listed on any  domestic
securities  exchange or quoted in the NASDAQ National  Market  or
the domestic over-the-counter market ("Unlisted Securities"), the
"Market Price" shall be the fair value thereof determined jointly
by the Company and the Holder.

           (d)  Consideration Other than Cash.  In the event that
Dilutive  Securities or Exchangeable Securities were  issued  for
consideration  other than cash, the per share  amounts  paid  for
such  Dilutive  Securities or Exchangeable  Securities  shall  be
determined  jointly  by the Company and the Participation  Rights
Holder.

           (e)   Appraiser.  If the Company and the Participation
Rights  Holder are unable to reach agreement within a  reasonable
period  of time with respect to (i) the Market Price of  Unlisted
Securities,  or  (ii)  the per share amounts  paid  for  Dilutive
Securities  or  Exchangeable Securities issued for  consideration
other than cash, such Market Price or per share amounts paid,  as
the  case  may  be,  shall be determined by an appraiser  jointly
selected by the Company and the Participation Rights Holder.  The
determination of such appraiser shall be final and binding on the
Company  and  the  Participation Rights  Holder.   The  fees  and
expenses of such appraiser shall be paid for by the Company.

      4.4   Prior  Percentage Interest.  A  Participation  Rights
Holder's "Prior Percentage Interest" for purposes of the Right of
Maintenance  is  the  ratio  of (a)  the  number  of  Registrable
Securities  held by such Participation Rights Holder  as  of  the
date  of such Maintenance Notice (as defined in Section 4.6) (the
"Notice  Date"),  to  (b) the difference between  (i)  the  total
number of shares of Common Stock of the Company (and other voting
securities  of  the Company, if any) outstanding  on  the  Notice
Date,  where  for such purposes all Warrant Shares  held  by  the
Investor   and  its  Majority  Owned  Subsidiaries   are   deemed
outstanding,  and  (ii) the total number of  Dilutive  Securities
issued since the later of the date of this Agreement or the  last
Notice  Date excluding any Maintenance Securities (defined below)
issued pursuant to the last Maintenance Notice.

      4.5   Maintenance Amount.  A Participation Rights  Holder's
"Maintenance Amount" with respect to any Maintenance Notice shall
equal  such  number  of  Maintenance Securities  as  shall  (upon
purchase  thereof  in  full by the Participation  Rights  Holder)
enable  such  Participation Rights Holder to maintain  its  Prior
Percentage  Interest on a fully-diluted basis.   As  an  example,
assume  that the Company had 10,000 shares outstanding,  and  the
Participation  Rights Holder holds 20% of such shares  (or  2,000
shares).   The Company first issues 400 shares to a  third  party
("Issuance  1"), an amount insufficient to trigger  a  Notice  of
Issuance pursuant to Section 4.6.  The Company then issues  4,600
shares  to a third party ("Issuance 2"), an amount sufficient  to
trigger  a  Notice of Issuance.  The Participation Rights  Holder
will   have  the  right  to  maintain  its  20%  interest   after
considering  Issuances 1 and 2 and the new shares issued  to  the
Participation

<PAGE> 17

Rights  Holder.  In this example, the Participation Rights Holder
will  have  the  right  to purchase an additional  1,250  shares,
thereby resulting in the Participation Rights Holder holding  20%
of  the  securities  outstanding  (3,250  shares  out  of  16,250
shares).

      4.6  Notice of Issuance.  Within fifteen (15) business days
of  each  anniversary of this Agreement, and within fifteen  (15)
business days of each issuance of Dilutive Securities which  when
cumulated  with all prior issuances of Dilutive Securities  since
the later of (i) the date of this Agreement, or (ii) the date  of
the  last  Notice  Date  (subsequent to which  the  Participation
Rights  Holder  has  had an opportunity to  purchase  Maintenance
Securities),  results  in  a five percent  (5%)  reduction  in  a
Participation  Rights  Holders' Prior  Percentage  Interest,  the
Company  shall  give to each Participation Rights Holder  written
notice  (the  "Maintenance  Notice")  describing  the  number  of
Dilutive Securities issued since such prior Notice Date  and  the
non-price  terms  upon  which the Company  issued  such  Dilutive
Securities, and the Maintenance Amount of Maintenance  Securities
that such Participation Rights Holder is entitled to purchase  as
a result of such issuances.

     4.7  Purchase of Maintenance Securities.  Each Participation
Rights  Holder shall have sixty (60) days from the receipt  of  a
Maintenance  Notice to elect to purchase up to such Participation
Rights Holder's Maintenance Amount of such Maintenance Securities
at  the  Purchase Price as defined in Section 4.3  and  upon  the
terms  and  conditions specified in the Maintenance Notice.   The
closing  of such purchase shall occur within ten (10) days  after
such  election  to purchase.  If any Participation Rights  Holder
fails  to  elect  to purchase such Participation Rights  Holder's
full  Maintenance  Amount of Maintenance Securities  within  such
sixty  (60)  day  period, then such Participation  Rights  Holder
shall  forfeit the right hereunder to purchase that part  of  its
Maintenance Amount that it did not so elect to purchase.

      4.8   Termination.  The provisions of Sections 4.1  through
4.7  shall terminate with respect to the issuance of any Dilutive
Securities  by  the  Company  after the  Right  of  Participation
terminates.

5.   RIGHTS IN CORPORATE EVENTS.

     5.l  Corporate Event.

           (a)   A  "Corporate  Event"  shall  mean  any  of  the
following,  whether  accomplished through  one  or  a  series  of
related  transactions (a) the acquisition of all or substantially
all  the assets of the Company, (b) an acquisition of the Company
by  consolidation, merger, share purchase or exchange,  or  other
reorganization  or  transaction  in  which  the  holders  of  the
Company's  outstanding  voting stock immediately  prior  to  such
transaction  own, immediately after such transaction,  securities
representing less than fifty percent (50%) of the voting power of
the  corporation or other entity surviving such transaction,  and
(c)  any  other  transaction or series  of  related  transactions
(excluding  any exercise or exercises of the Warrant) that  would
result in a greater than twenty-five percent (25%) change in  the
total  outstanding number of shares of Voting Stock  (as  defined
below)  of  the Company (other than any such change solely  as  a
result of a stock split, stock dividend or other recapitalization
affecting  holders  of Common Stock and other classes  of  voting
securities of the Company on a pro rata basis).

<PAGE> 18

           (b)   The  Company  agrees that it  will  provide  the
Investor with detailed written notice of any offer from  a  third
party for a proposed Corporate Event within two (2) business days
of  the  date  the Company first becomes aware of such  offer  or
proposed  Corporate Event.  In addition, the Company agrees  that
it will provide the Investor, within two (2) business days of the
Company's becoming aware thereof, with detailed written notice of
any offer from a third party to acquire ten percent (10%) or more
of the Company's outstanding voting securities.

      5.2   Right of First Refusal  The Company agrees that prior
to  entering  into any agreement for what would be  considered  a
Corporate  Event,  the Company will present to  the  Investor  in
writing  the final terms and conditions of the proposed Corporate
Event,  including without limitation the name of the other  party
or  parties  to the Corporate Event and a copy of the  definitive
agreements  that  the  Company is prepared  to  enter  into  (the
"Corporate Event Agreement").  The Investor shall have  ten  (10)
calendar  days  from the date of receipt of the  Corporate  Event
Agreement  to deliver written notice to the Company  agreeing  in
writing   to  enter  into  an  agreement  with  the  Company   on
substantially  the  same terms and conditions  specified  in  the
Corporate  Event  Agreement,  which  agreement  shall  call   for
completion within one hundred twenty (120) days from the date  of
delivery  of  the Corporate Event Agreement (such 120-day  period
subject  to  extensions  for  regulatory  compliance).   If   the
Investor  fails  to  so  agree in writing within  such  ten  (10)
business  day  period, for a period of one hundred  twenty  (120)
days  thereafter, the Company shall have the right to enter  into
the  Corporate Event Agreement  with the party specified in  such
agreement.

      5.3   Termination of Rights.  The rights  of  the  Investor
under Section 5.23 shall terminate after July 13, 2000; provided,
however, that the Investor's rights under such sections  of  this
Section  5 shall remain in full force and effect with respect  to
any  Corporate Event for which the Investor has received, or been
entitled  to receive, notice from the Company prior to  July  13,
2000.

      5.4   Right of First Negotiation.  After July 13, 2000  and
through  July  13, 2004 (before July 13, 2000, the provisions  of
Section  5.2  shall govern), prior to entering into a  definitive
agreement  with respect to a Corporate Event, the  Company  shall
first attempt to negotiate in good faith with the Investor for  a
period  of  not  less  than twenty (20) calendar   days  for  the
Investor  to acquire the Company or enter into another  Corporate
Event with the Company.  During such 20-calendar day period,  the
Investor  shall  be  entitled to conduct due diligence  with  the
reasonable  cooperation of the Company.  To the extent  that  the
Company  and  the  Investor do not enter into an  agreement  with
respect to such an acquisition or other Corporate Event with  the
Investor during such 20-calendar day period, the Company shall be
free  to  enter  into a definitive agreement with  respect  to  a
Corporate  Event  with a third party and subsequently  consummate
such Corporate Event, provided that such definitive agreement  is
entered  into  within ninety (90) days following  termination  of
such  20-calendar  day  period, and, provided  further,  that  if
during such 20-calendar day period, the Investor shall have  made
a written offer for the acquisition of the Company, the Corporate
Event  with  such a third party shall be for at least ninety-five
percent  (95%) of the price offered by the Investor and on  other
terms  no less favorable to shareholders of the Company than  the
terms  of  the  offer proposed by the Investor  with  respect  to
shareholders  other  than  the  Investor.   The  Investor   shall
reasonably cooperate with the Company and other

<PAGE> 19

persons to effect such Corporate Event with such third party and,
if  the  Investor votes in favor of such Corporate  Event,  shall
comply with applicable pooling-of-interests restrictions.

6.   ASSIGNMENT AND AMENDMENT.

      6.1   Assignment.  Notwithstanding anything herein  to  the
contrary:

           (a)   Information Rights.  The rights of the  Investor
under Section 1.1 are transferable to any Holder who acquires and
holds  at  least  250,000  Registrable  Securities  (subject   to
appropriate   adjustment   for  all  stock   splits,   dividends,
combinations, recapitalizations and the like where all holders of
the  Company's  Common Stock participate on a  pro  rata  basis);
provided,  however,  that no party may be  assigned  any  of  the
foregoing  rights unless the Company is given written  notice  by
the  assigning party at the time of such assignment  stating  the
name  and  address of the assignee and identifying the securities
of  the  Company  as  to which the rights in question  are  being
assigned;  and  provided  further that any  such  assignee  shall
receive  such  assigned  rights subject  to  all  the  terms  and
conditions  of  this Agreement, including without limitation  the
provisions  of this Section 6.  The rights of the Investor  under
Section 1.2 may not be assigned.

           (b)  Registration Rights.  The registration rights  of
the  Investor  under  Section 2 hereof may  be  assigned  to  any
Holder; provided, however, that no party may be assigned  any  of
the  foregoing rights unless the Company is given written  notice
by the assigning party at the time of such assignment stating the
name  and  address of the assignee and identifying the securities
of  the  Company  as  to which the rights in question  are  being
assigned;  and  provided  further that any  such  assignee  shall
receive  such  assigned  rights subject  to  all  the  terms  and
conditions  of  this Agreement, including without limitation  the
provisions of this Section 6.

           (c)   Rights  of  Participation and Maintenance.   The
rights of the Investor under Sections 3 and Section 4 hereof  may
be   assigned  only  to  a  subsidiary  of  which  the   Investor
beneficially owns, either directly or indirectly, at least 50% of
the  voting securities (a "Majority Owned Subsidiary"); provided,
however that no party may be assigned any of the foregoing rights
unless the Company is given written notice by the Investor at the
time  of  such  assignment stating the name and  address  of  the
assignee  and  identifying the securities of the ;Company  as  to
which  the  rights in question are being assigned;  and  provided
further that any such assignee shall receive such assigned rights
subject to all the terms and conditions of this Agreement.

           (d)   Rights On Corporate Events.  The rights  of  the
Investor  under Section 5 hereof may be assigned only  in  whole,
and  not  in  part,  and  only  to a Majority  Owned  Subsidiary;
provided,  however  that  no party may be  assigned  any  of  the
foregoing  rights unless the Company is given written  notice  by
the  Investor at the time of such assignment stating the name and
address  of  the  assignee; and provided further  that  any  such
assignee  shall receive such assigned rights subject to  all  the
terms and conditions of this Agreement.

      6.2   Amendment of Rights.  Any provision of this Agreement
may  be  amended and the observance thereof may be waived (either
generally or in a particular instance and either retroactively or
prospectively), only with the written consent of the Company  and
Investor  (or,  in  the case of an amendment  or  waiver  of  any
provision of Section 2 hereof, only with the written

<PAGE> 20

consent  of  the  Company and the Holders of a  majority  of  the
Registrable  Securities  then outstanding  and  entitled  to  the
registration  rights  set  forth  in  Section  2  hereof).    Any
amendment or waiver effected in accordance with this Section  6.2
shall  be  binding upon the Investor, each Holder, each permitted
successor or assignee of such Investor or Holder and the Company.

7.   CONFIDENTIALITY.

      7.1   (a)  Except to the extent required by law or judicial
order  or except as provided herein, each party to this Agreement
will hold any of the other's Confidential Information (as defined
in  the next paragraph) in confidence and will: (i) use the  same
degree  of care to prevent unauthorized disclosure or use of  the
Confidential Information that the receiving party uses  with  its
own  information  of  like nature (but  in  no  event  less  than
reasonable  care),  (ii)  limit disclosure  of  the  Confidential
Information,  including any materials regarding the  Confidential
Information that the receiving party has generated,  to  such  of
its  employees  and  contractors as  have  a  need  to  know  the
Confidential  Information  to accomplish  the  purposes  of  this
Agreement, and (iii) advise its employees, agents and contractors
of the confidential nature of the Confidential Information and of
the receiving party's obligations under this Agreement.

            (b)    For  purposes  of  this  Agreement,  the  term
"Confidential Information" refers to the following items relating
to  the confidential and proprietary information, including trade
secrets,  of  the  disclosing party: (i)  all  written  materials
provided  by  the  disclosing party that are  clearly  marked  as
confidential,  (ii)  any  tangible  materials  provided  by   the
disclosing  party  that are clearly marked as  confidential,  and
(iii) all information that is orally or visually disclosed by the
disclosing party if it is identified as confidential at the  time
of  disclosure  and  is reduced to a summary  written  disclosure
delivered  to the receiving party within thirty (30)  days  after
the  original  disclosure.  "Confidential Information"  will  not
include, even if marked as confidential, materials or information
which:   (i)   is   rightfully  known  without   obligations   of
confidentiality by the receiving party, (ii) is or becomes public
knowledge  through  no wrongful act of the receiving  party,  its
agent,  employees or affiliates, (iii) is rightfully received  by
the   receiving  party  from  another  party  authorized  by  the
disclosing  party to disseminate such materials  or  information,
(iv)  is  independently developed by the receiving party  without
breach  of  this  Agreement, or (v) is approved  in  writing  for
release  by the disclosing party.  Any employee or contractor  of
the receiving party having access to the Confidential Information
will  be  required to sign a non-disclosure agreement  protecting
the  Confidential Information if not already bound by such a non-
disclosure agreement.

      7.2  Except to the extent required by law or judicial order
or  except as provided herein, neither party shall disclose  this
Agreement  or any of its terms without the other's prior  written
approval,  which  approval will not be  delayed  or  unreasonably
withheld.  Either party may disclose this Agreement to the extent
required  by  law  or  judicial  order,  provided  that  if  such
disclosure  is  pursuant to judicial order  or  proceedings,  the
disclosing party will notify the other party promptly before such
disclosure  and  will  cooperate with the  other  party  to  seek
confidential   treatment  with  respect  to  the  disclosure   if
requested  by the other party and provided further that  if  such
disclosure  is required pursuant to the rules and regulations  of
any  federal,  state  or  local organization,  the  parties  will
cooperate to seek confidential treatment of this Agreement to the
maximum extent possible under law.

<PAGE> 21

      7.3   Prior to the execution of this Agreement, the parties
will agree on the content of a joint press release announcing the
existence  of this Agreement, which press release will be  issued
as mutually agreed by the parties.

     7.4  Neither party will be required to disclose to the other
any  confidential information of any third party  without  having
first obtained such third party's prior written consent.

      7.5   The provisions of this Section 7 shall survive for  a
period  of five (5) years from the date which the Investor ceases
to  have  any  rights  under Sections 1,  3,  4  and  5  of  this
Agreement.

8.   STANDSTILL AGREEMENT.

      8.1   Standstill.   The  Investor hereby  agrees  that  the
Investor  (together  with all Majority Owned Subsidiaries)  shall
neither   acquire,  nor  enter  into  discussions,  negotiations,
arrangements or understandings with any third party  to  acquire,
beneficial ownership (as defined in Rule 13d-3 promulgated  under
the  Securities Exchange Act of 1934, as amended) of  any  Voting
Stock  (as  defined  below), any securities convertible  into  or
exchangeable  for  Voting Stock, or any other  right  to  acquire
Voting  Stock (except, in any case, by way of stock dividends  or
other distributions or offerings made available to holders of any
Voting  Stock  generally)  without the  written  consent  of  the
Company,  if the effect of such acquisition would be to  increase
the  Voting  Power  (as defined below) of all Voting  Stock  then
beneficially owned (as defined above) by the Investor or which it
has  a  right  to  acquire  (together  with  all  Majority  Owned
Subsidiaries)  to a percentage greater than twenty-two  and  one-
half  percent (22.5%) (the "Standstill Percentage") of the  Total
Voting  Power (as defined below) of the Company at  the  time  in
effect; provided that nothing in this Section 8 shall affect  the
Investors  rights  under Section 3 and Section  4,  and  provided
further that:

           (a)   The  Investor may acquire Voting  Stock  without
regard to the foregoing limitation, and such limitation shall  be
suspended, but not terminated, if and for as long as (i) a tender
or  exchange offer is made and is not withdrawn or terminated  by
another person or group to purchase or exchange for cash or other
consideration any Voting Stock that, if accepted or if  otherwise
successful,  would  result in such person or  group  beneficially
owning or having the right to acquire shares of Voting Stock with
aggregate Voting Power of more than twenty-five percent (25%)  of
the  Total  Voting  Power  of the Company  then  in  effect  (not
counting  for  these purposes any shares of Voting Stock  of  the
Company  originally  acquired  (  where  such  Shares  or  shares
exchanged with the Company in respect thereof, are still held) by
such  person  or  group from the Investor or any  Majority  Owned
Subsidiary), and such offer is not withdrawn or terminated  prior
to  the  Investor  making  an offer to acquire  Voting  Stock  or
acquiring  Voting  Stock; provided, however, that  the  foregoing
standstill limitation will be reinstated once any such tender  or
exchange offer is withdrawn or terminated, (ii) another person or
group hereafter acquires Voting Stock with aggregate Voting Power
of  more than ten percent (10%) of the Total Voting Power of  the
Company  then  in  effect (not counting for  these  purposes  any
shares  of Voting Stock of the Company originally acquired (where
such  Shares  or  shares exchanged with the  Company  in  respect
thereof,  are  still  held)  by such person  or  group  from  the
Investor or any Majority Owned Subsidiary), where such person  or
group  files  a  Schedule 13D (under the rules promulgated  under
Section  13(d) under the Securities and Exchange Act of 1934,  as
such rules and section are in

<PAGE> 22

effect  on  the  date  hereof), or  other  similar  or  successor
schedule  or  form,  indicating that  such  person's  or  group's
holdings  exceed ten percent (10%); provided, however,  that  the
foregoing  standstill  limitation will  be  reinstated  once  the
percentage of Total Voting Power beneficially owned by such other
person  or  group  falls below ten percent (10%);  (iii)  another
person  or group hereafter acquires Voting Stock that results  in
such  person or group being required to file a Schedule  13G,  or
other similar or successor schedule or form, indicating that such
other  person  or  group beneficially owns or has  the  right  to
acquire  Voting Stock with aggregate Voting Power  of  more  than
twenty  percent  (20%) of the Total Voting Power of  the  Company
(not  counting for these purposes any shares of Voting  Stock  of
the  Company  originally acquired (where such  Shares  or  shares
exchanged with the Company in respect thereof, are still held) by
such  person  or  group from the Investor or any  Majority  Owned
Subsidiary);  provided,  however, that the  foregoing  standstill
limitation will be reinstated once the percentage of Total Voting
Power  beneficially  owned by such other person  or  group  falls
below  ten percent (10%); or (iv) another person or group  orally
or  in  writing contacts the Company and advises the  Company  of
such  person's   or  group's intention to commence  a  tender  or
exchange  offer  that,  if  so  commenced,  would  result  in   a
suspension  pursuant  to clause (i) above  (e.g.,  a  "bear  hug"
offer);   provided,   however,  that  the  foregoing   standstill
limitation  will be reinstated if such intention is withdrawn  in
writing  or  other  reasonable evidence  of  such  withdrawal  is
provided  to the Investor.  The Company shall notify the Investor
in  writing  of the occurrence of any event described in  clauses
(i) through (iv) of the immediately preceding sentence as soon as
practicable  following the Company's becoming aware of  any  such
event, and in any case, shall provide the Investor written notice
of  any  such event within two (2) business days of the Company's
being aware of the occurrence of any such event.

          (b)  The Investor will not be obliged to dispose of any
Voting  Stock to the extent that the aggregate percentage of  the
Total  Voting  Power of the Company represented by  Voting  Stock
beneficially  owned by the Investor or which the Investor  has  a
right  to  acquire is increased beyond the Standstill  Percentage
(i)  as  a  result  of a recapitalization of  the  Company  or  a
repurchase or exchange of securities by the Company or any  other
action taken by the Company or its affiliates; (ii) as the result
of  acquisitions of Voting Stock made during the period when  the
Investor's  "standstill" obligations are  suspended  pursuant  to
Section 8.1(a); (iii) as a result of an equity index transaction,
provided that Investor shall not vote such shares; (iv) by way of
stock  dividends  or other distributions or rights  or  offerings
made  available  to holders of shares of Voting Stock  generally;
(v)  with  the  consent of a simple majority of  the  independent
authorized members of the Company's Board of Directors;  or  (vi)
as  part of a transaction on behalf of Investor's Defined Benefit
Pension  Plan,  Profit  Sharing Retirement Plan,  401(k)  Savings
Plan,  Sheltered Employee Retirement Plan and Sheltered  Employee
Retirement  Plan Plus, or any successor or additional  retirement
plans  thereto (collectively, the "Retirement Plans")  where  the
Company's shares in such Retirement Plans are voted by a  trustee
for  the  benefit of Investor employees or, for those  Retirement
Plans  where Investor controls voting, where Investor agrees  not
to  vote  any  shares of such Retirement Plan Voting  Stock  that
would cause Investor to exceed the Standstill Percentage.

           (c)   As  used in this Section 8, (i) the term "Voting
Stock" means the Common Stock and any other securities issued  by
the Company having the ordinary power to vote in the

<PAGE> 23

election  of  directors  of the Company  (other  than  securities
having  such power only upon the happening of a contingency  that
has  not  occurred), (ii) the term "Voting Power" of  any  Voting
Stock means the number of votes such Voting Stock is entitled  to
cast  for directors of the Company at any meeting of shareholders
of the Company, and (iii) the term "Total Voting Power" means the
total  number  of  votes which may be cast  in  the  election  of
directors  of the Company at any meeting of shareholders  of  the
Company  if  all Voting Stock was represented and  voted  to  the
fullest  extent possible at such meeting, other than  votes  that
may be cast only upon the happening of a contingency that has not
occurred.  For purposes of this Section 8, the Investor shall not
be  deemed to have beneficial ownership of any Voting Stock  held
by  a  pension  plan  or other employee benefit  program  of  the
Investor  if the Investor does not have the power to control  the
investment decisions of such plan or program.

      8.2  Right of First Refusal upon Section 8.1(a) Event.   If
the   Investor  or  any  Majority  Owned  Subsidiary  elects   to
participate and tender or exchange any of the Shares, the Warrant
and/or  the  Warrant  Shares pursuant to any event  described  in
clause  (i) of the first sentence of Section 8.1(a), the Investor
shall  provide written notice of such intention to  the  Company.
The  Company  shall have five (5) business days from delivery  of
such  notice to elect to purchase all, but not less than all,  of
such  Shares  from the Investor or Majority Owned Subsidiary  for
cash, at the Offer Price (as defined below) per share offered  by
the  person  or  group in the event described in clause  (i),  by
delivering  an  irrevocable written election by  the  Company  to
purchase  such  Shares at such price.  In the event  the  Company
delivers such written election, the Company shall be obligated to
purchase, and the Investor or Majority Owned Subsidiary shall  be
obligated to sell, such Shares within ten (10) business  days  of
delivery  of the Company's written election to the Investor.   If
the  Company  fails to deliver such written election  within  the
five (5) business day period described above or fails to purchase
such  Shares  within the ten (10) business day  period  described
above,  it shall forfeit its rights under this Section  8.2  with
respect to such tender or exchange, regardless whether the  terms
and  conditions  of such tender or exchange may  subsequently  be
modified.  As used herein, "Offer Price" means (a) in the case of
a cash offer, the amount of cash per share to be paid; (b) in the
case  of a share offer where the shares offered are listed on  an
exchange or quoted on the Nasdaq National Market, an amount equal
to  the average of the closing prices of such security's sales on
all  domestic securities exchanges on which said security may  at
the  time be listed, or, if there have been no sales on any  such
exchange  on such day, the average of the highest bid and  lowest
asked prices on all such exchanges at the end of such day, or, if
on  any  day such security is not so listed, the average  of  the
representative bid and asked prices quoted in the NASDAQ National
Market  as  of 4:00 p.m., New York time, or, if on any  day  such
security is not quoted in the NASDAQ National Market, the average
of  the  highest bid and lowest asked prices on such day  in  the
domestic  over-the-counter market as  reported  by  the  National
Quotation   Bureau,   Incorporated,  or  any  similar   successor
organization,  all  determined as of the date written  notice  is
delivered  to the Company by the Investor pursuant to  the  first
sentence  of this Section 8.2; or (c) in the event of  any  other
tender  or  exchange  offer, the value of the  securities  and/or
other  property as set forth in the offer by the person or  group
making such offer.

      8.3   Right of First Refusal upon Transfer of Five  Percent
Stake.   In  circumstances other than those described in  Section
8.2, if the Investor intends to sell Voting Stock (including  the
Voting  Stock underlying any portion of the Warrants proposed  to
be sold) with Voting Power

<PAGE> 24

constituting  more than five percent or more of the Total  Voting
Power  (or  intends  to sell Voting Stock (including  the  Voting
Stock  underlying  any such portion of the Warrant)  with  Voting
Power  constituting  less than five percent  (5%)  of  the  Total
Voting  Power to any person which beneficially owns five  percent
(5%) or more of the Total Voting Power as indicated on a Schedule
13D  or  13G  filed  with  the SEC), the Investor  shall  provide
written  notice  thereof to the Company (the "Investor  Notice").
The  Investor Notice shall specify the number of Shares involved,
the  name and address of the proposed purchaser, and the proposed
price  per  Share.  For a period of five (5) business days  after
delivery of the Investor Notice, the Company shall be entitled to
elect  to  purchase  all, but not less than all,  of  the  Shares
described  in  the  Investor  Notice,  at  the  price  per  share
described  in  such  notice, by delivery of a written  notice  (a
"Company Purchase Election") to the Investor irrevocably electing
to  purchase such Shares and shall have thirty (30) business days
to consummate said purchase from the Investor.  In the event that
the  Company has not delivered a Company Purchase Election  prior
to  the  expiration of such five (5) business-day period  or  has
failed  to  purchase such Shares within said thirty (30)-business
day  period,  the Company's right to purchase such  Shares  shall
expire,  and the Investor or Majority Owned Subsidiary  shall  be
entitled to sell the Shares described in the Investor Notice  for
a period of ninety (90) days following the expiration of such 90-
day  period, but only to the proposed purchaser set forth in  the
Investor  Notice (or any Majority Owned Subsidiary  thereof)  and
only for a purchase price equal to at least ninety-five (95%)  of
the  purchase  price set forth in the Investor  Notice.   In  the
event the Investor or Majority Owned Subsidiary has not sold such
Shares  by  the  end  of such 90-day period, the  rights  of  the
Company  set forth above in this Section 8.3 shall apply  to  any
subsequent  sales  by the Investor or Majority Owned  Subsidiary.
Notwithstanding the foregoing, the provisions of this Section 8.3
shall  not apply to any sales or other transfers by the  Investor
to any Majority Owned Subsidiary.

      8.4   Termination of Standstill.  The provisions of Section
8.1 shall terminate on the second anniversary of the date of this
Agreement.   The  provisions  of  Sections  8.2  and  8.3   shall
terminate  when  the Investor (together with all  Majority  Owned
Subsidiaries)  shall  cease to beneficially  own  at  least  five
percent  (5%) of the Total Voting Power of the Company; provided,
however,  that for purposes of determining beneficial  ownership,
the  number of Warrant Shares underlying the unexercised  portion
of the Warrant shall be included.

9.   VOTING AGREEMENT.

     9.1  Proportional Voting.  Whenever the Investor directly or
indirectly  owns (of record or beneficially) Voting  Stock  which
constitutes  five percent (5%) or more of the Total Voting  Power
of  the  Company,  the  Investor agrees to vote  all  Registrable
Securities  of  the Company then owned directly or indirectly  by
the   Investor,  that  consist  of  Voting  Stock,  in  the  same
proportion  as  the  votes  cast by  all  other  holders  of  the
Company's  Voting Stock, except on matters that the Investor,  in
its  reasonable discretion, deems could potentially be materially
adverse to the Investor's interests.

      9.2   No Dissent.  The Investor hereby agrees that it  will
not exercise dissenter's or appraisal rights or otherwise dissent
or  seek appraisal rights with respect to any Corporate Event  or
any  other merger or acquisition involving the Company  (e.g.  an
acquisition by the Company of a third party), provided  that,  in
the event that the provisions of Section 5 hereof have not been

<PAGE> 25

terminated, the provisions of this Section 9.2 shall  only  apply
with  respect  to  such  a Corporate Event  if  the  Company  has
complied with the applicable provisions of Section 5 with respect
to such Corporate Event.

      9.3  Survival.  The provisions of Section 9 shall terminate
on  the  fifth  anniversary of the Closing  (as  defined  in  the
Purchase Agreement).

10.  GENERAL PROVISIONS.

      10.1 Notices.  Any notice required or permitted under  this
Agreement  will  be  given in writing, shall  be  effective  when
received,  and  shall  in  any  event  be  deemed  received   and
effectively  given  upon personal delivery to  the  party  to  be
notified or three (3) business days after deposit with the United
States  Post  Office,  by registered or certified  mail,  postage
prepaid,  or one (1) business day after deposit with a nationally
recognized  courier service such as Fedex for next  business  day
delivery,  or  one  (1) business day after  facsimile  with  copy
delivered  by registered or certified mail, postage  prepaid  and
addressed  to  the party to be notified at the address  indicated
for  such  party on the signature page hereof or  at  such  other
address as the Investor or the Company may designate by giving at
least  ten  (10)  days advance written notice  pursuant  to  this
Section 10.1.

          (a) if to the Investor, at:  Intel Corporation
                                       2200 Mission College
                                       Boulevard
                                       Santa Clara, California
                                       95052
                                       Attention:  Treasurer
              Telephone No.:           (408) 765-1240
              Facsimile No.:           (408) 765-1611
                                       and
                                       Attention:  General
                                       Counsel
              Telephone No.:           (408) 765-1125
              Facsimile No.:           (408) 765-1859
                                       
              with a copy to:          Gibson, Dunn & Crutcher
                                       LLP
                                       One Montgomery Street
                                       Telesis Tower
                                       San Francisco, California
                                       94104-4505
                                       Attention:  Kenneth R.
                                       Lamb
              Telephone No.:           (415) 393-8382
              Facsimile No.:           (415) 986-5309
                                       
          (b) if to the Company, at:   Xircom, Inc.
                                       2300 Corporate Center
                                       Drive
                                       Thousand Oak, California
                                       91230
                                       Attention:  General
                                       Counsel
              Telephone No.:           (805) 376-9300
              Facsimile No.:           (805) 376-9120
<PAGE> 26                              
              with a copy to:          Wilson Sonsini Goodrich &
                                       Rosati
                                       650 Page Mill Road
                                       Palo Alto, California
                                       94304-1050
                                       Attention:  Larry Sonsini
                                       and Howard Zeprun
              Telephone No.:           (415) 493-9300
              Facsimile No.:           (415) 493-6811
                                       
Any  party  hereto (and such party's permitted  assigns)  may  by
notice  so given change its address for future notices hereunder.
Notice  shall  conclusively be deemed to  have  been  given  when
personally delivered or when deposited in the mail in the  manner
set  forth  above.   Any  notice  provided  to  the  Investor  in
accordance  with this Section 10.1 shall be deemed to  have  also
been  given  to  any Majority Owned Subsidiary,  and  any  notice
provided  by  the Investor to the Company shall  also  be  deemed
notice  by  its  Majority Owned Subsidiaries, and they  shall  be
bound thereby.

      10.2  Entire Agreement.  This Agreement, together with  all
the   Exhibits  hereto,  constitutes  and  contains  the   entire
agreement  and understanding of the parties with respect  to  the
subject   matter  hereof  and  supersedes  any  and   all   prior
negotiations, correspondence, agreements, understandings,  duties
or  obligations between the parties respecting the subject matter
hereof.

     10.3 Governing Law.  This Agreement shall be governed by and
construed exclusively in accordance with the internal laws of the
State  of  California as applied to agreements  among  California
residents  entered  into  and  to be  performed  entirely  within
California,  excluding that body of law relating to  conflict  of
laws and choice of law.

      10.4  Severability.   If  one or more  provisions  of  this
Agreement are held to be unenforceable under applicable law, then
such  provision(s) shall be excluded from this Agreement and  the
balance  of  this  Agreement  shall be  interpreted  as  if  such
provision(s)  were  so  excluded  and  shall  be  enforceable  in
accordance with its terms.

      10.5 Third Parties.  Nothing in this Agreement, express  or
implied,  is intended to confer upon any person, other  than  the
parties  hereto and their permitted successors and  assigns,  any
rights or remedies under or by reason of this Agreement.

      10.6 Successors And Assigns.  Subject to the provisions  of
Section 6.1, the provisions of this Agreement shall inure to  the
benefit  of,  and  shall  be  binding upon,  the  successors  and
permitted assigns of the parties hereto.

      10.7  Captions.  The captions to sections of this Agreement
have been inserted for identification and reference purposes only
and shall not be used to construe or interpret this Agreement.

      10.8  Counterparts.   This Agreement  may  be  executed  in
counterparts, each of which shall be deemed an original, but  all
of which together shall constitute one and the same instrument.

<PAGE> 27

      10.9  Adjustments for Stock Splits, Etc.  Wherever in  this
Agreement there is a reference to a specific number of shares  of
Common  Stock  of the Company, then, upon the occurrence  of  any
subdivision, combination or stock dividend of Common  Stock,  the
specific  number of shares so referenced in this Agreement  shall
automatically be proportionally adjusted to reflect the affect on
the  outstanding shares of such class or series of stock by  such
subdivision, combination or stock dividend.

    [The remainder of this page is intentionally left blank.]
                                
<PAGE> 28

      IN  WITNESS WHEREOF, the parties hereto have executed  this
Agreement as of the date and year first above written.

Xircom, Inc.                        Intel Corporation
                                    
By:  /s/Randall H. Holliday         By:  /s/Satish Rishi
Name:  Randall H. Holliday          Name:  Satish Rishi
Title:  Secretary and General       Title:  Assistant Treasurer
          Counsel                   
                                    

          [Signature Page to Investor Rights Agreement]
                                






                            EXHIBIT 4
                                
                        PRESS RELEASE OF
                                
                          XIRCOM, INC.
                                
                              DATED
                                
                        JANUARY 16, 1997
                                
<PAGE>

              XIRCOM RECEIVES INVESTMENT FROM INTEL
                                
           Companies Also Sign Three-Year, Technology
   and OEM Agreement to Further Advance Mobile Communications
                                
Thousand  Oaks,  Calif., Jan. 16, 1997 -  Xircom,  Inc.  (NASDAQ:
XIRC),   the   leader  in  connectivity  solutions   for   mobile
professionals,  announced today that the company  has  signed  an
agreement with Intel Corporation, the world's largest chip  maker
(NASDAQ:   INTC),  in which Intel will purchase  a  12.5  percent
interest  in Xircom (2.5 million shares) and acquire warrants  to
obtain  an  additional  7.5 percent of the company's  stock  (1.5
million   shares).   The  value  of  the  initial  Intel   equity
investment in Xircom is $52 million.

In addition, Xircom and Intel have signed a three-year technology
and  multi-million  dollar  OEM  agreement.   As  a  result,  the
companies  plan  to  work  together  to  further  advance  mobile
connectivity solutions for high-performance business computing.

"Xircom  is  the  key  provider of mobile network  solutions  and
shares   Intel's  goal  to  provide  high-performance  networking
technology   that   advances  the  connected   PC,"   said   Mark
Christensen,    vice   president   of   Intel's   Internet    and
Communications  Group  and  general manager  of  Intel's  Network
Products  Division.  "By working together, Intel and Xircom  will
evolve the network connectivity industry and fulfill a very  real
customer need in using high-performance, Intel architecture-based
mobile PCs as strategic business tools."

"The  corporate alliance brings together world leaders in  mobile
connectivity  and  microprocessors  to  jointly  deliver  desktop
connectivity  performance  to mobile  computers,"  said  Dirk  I.
Gates, chairman, president and chief executive officer of Xircom,
Inc.  "This agreement also signals a growing trend that notebooks
can  be  a  flexible and strategic alternative for  desktop  PCs.
Both  firms  are committed to delivering solutions  designed  for
today's as well as tomorrow's portable computing environments."

Xircom  Corporate  Background.  Founded in 1988,  Xircom  is  the
leading  manufacturer  of  PC  Card communications  products  for
connecting mobile and remote portable computer users to corporate
networks,  the Internet, and other online services  from  a  wide
variety of locations.  World Wide Web:  http://www.xircom.com.

Intel  Corporate  Background.  Intel, the  world's  largest  chip
maker,  is  also  a  leading manufacturer of  personal  computer,
networking   and  communications  products.   Through  innovative
technologies,  Intel is committed to advancing the  connected  PC
for  high performance business computing.  Additional information
is available at http://www.intel.com/pressroom.







                            EXHIBIT 5
                                
                        PRESS RELEASE OF
                                
                          XIRCOM, INC.
                                
                              DATED
                                
                          MARCH 3, 1997
                                
<PAGE>

        XIRCOM EQUITY INVESTMENT FROM INTEL IS FINALIZED
                                
         Shares Have Been Issued, Funds Transferred and
     Products are Shipping From Xircom to Intel Corporation
                                
Thousand  Oaks,  Calif., March 3, 1997 -  Xircom,  Inc.  (NASDAQ:
XIRC),   the   leader  in  connectivity  solutions   for   mobile
professionals,  announced today that Intel  Corporation's  equity
investment in Xircom, valued at $52 million, has been completed.

On  January  16,  1997, Xircom reported that it  had  reached  an
agreement  with  Intel,  in which Intel  would  purchase  a  12.5
percent interest in the company's stock (2,516,405 million  newly
issued  shares) and acquire warrants to obtain an additional  7.5
percent of the company's stock (1,509,903 million shares).   This
transaction  is  now finalized.  In addition,  Xircom  has  begun
shipping products to Intel under a three-year technology and  OEM
agreement, also announced on January 16, 1997.

"We  are pleased to report that this transaction is fully  funded
and  that the first products are shipping from Xircom to  Intel,"
said  Dirk Gates, chairman, president and chief executive officer
of  Xircom.   "We look forward to a long and mutually  beneficial
relationship."

Notice  to  Reader:   This news release contains  forward-looking
statements based on current expectations that involve a number of
risks  and  uncertainties  which could cause  actual  results  to
differ  materially  and include, but are not limited  to,  future
shipments  under  the Intel OEM arrangement and introduction  and
market  acceptance of new products.  Other additional  risks  are
described in the company's SEC report on Form 10-K for the fiscal
year ended September 30, 1996.  Investor information may be found
on  Xircom's  web  site at www.xircom.com or on the  SEC's  EDGAR
electronic filing database.

Xircom  Corporate  Background.  Founded in 1988,  Xircom  is  the
leading  manufacturer  of  PC  Card communications  products  for
connecting mobile and remote portable computer users to corporate
networks,  the Internet, and other online services  from  a  wide
variety of locations.  World Wide Web:  http://www.xircom.com.

                              # # #
                                
For more information, contact:
Kristi Cushing
Xircom, Inc.
805-376-6968
[email protected]

Xircom  is  a registered trademark of Xircom, Inc.  GlobalACCESS,
CreditCard  Ethernet+Modem, CreditCard Modem, CountrySelect,  and
Netaccess  are trademarks of Xircom, Inc.  Other company  product
names have been used for identification purposes only and may  be
trademarks   of   their   respective   companies.    Xircom    is
headquartered in Thousand Oaks, Calif., and has regional  offices
in  Salem, N.H., Antwerp, Belgium, and Singapore.  Sales:   (800)
438-4526.  Telephone:  (805) 376-9300; Fax:  (805) 376-9311.








© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission